| Year |
Citation |
Score |
| 2024 |
Kean LS, Burns LJ, Kou TD, Kapikian R, Lozenski K, Langston A, Horan JT, Watkins B, Qayed M, Bratrude B, Betz K, Tang XY, Zhang MJ, Connolly SE, Polinsky MS, et al. Abatacept for acute graft-versus-host disease prophylaxis after unrelated donor hematopoietic cell transplantation. Blood. PMID 39028876 DOI: 10.1182/blood.2023023660 |
0.366 |
|
| 2023 |
Murthy HS, Zhang MJ, Chen K, Ahmed S, Deotare U, Ganguly S, Kansagra A, Michelis FV, Nishihori T, Patnaik MM, Abid MB, Aljurf M, Arai Y, Bacher U, Badar T, et al. Allogeneic Hematopoietic Cell Transplantation for Blastic Plasmacytoid Dendritic Cell Neoplasm: a CIBMTR analysis. Blood Advances. PMID 37792849 DOI: 10.1182/bloodadvances.2023011308 |
0.366 |
|
| 2023 |
Magenau JM, Jaglowski SM, Uberti J, Farag SS, Mansour Riwes M, Pawarode A, Anand S, Ghosh M, Maciejewski J, Braun TM, Devenport M, Lu S, Banerjee B, DaSilva C, Devine SM, ... Zhang MJ, et al. A Phase 2 Trial of CD24Fc for Prevention of Graft-vs-Host Disease. Blood. PMID 37647633 DOI: 10.1182/blood.2023020250 |
0.306 |
|
| 2023 |
Abid MB, Merly NE, Zhang MJ, Chen K, Bredeson C, Allan D, Sabloff M, Marks DI, Litzow M, Hourigan C, Kebriaei P, Saber W. Younger Matched Unrelated Donors Confer Decreased Relapse Compared to Older Sibling Donors in Older B-cell ALL Patients Undergoing Allogeneic Hematopoietic Cell Transplantation. Transplantation and Cellular Therapy. PMID 37481243 DOI: 10.1016/j.jtct.2023.07.015 |
0.385 |
|
| 2023 |
Cohen S, Bambace N, Ahmad I, Roy J, Tang X, Zhang MJ, Burns LJ, Barabé F, Bernard L, Delisle JS, Kiss T, Lachance S, Roy DC, Veilleux O, Sauvageau G. Improved Outcomes of UM171-Expanded Cord Blood Transplantation Compared with Other Graft Sources: Real-World Evidence. Blood Advances. PMID 37467030 DOI: 10.1182/bloodadvances.2023010599 |
0.428 |
|
| 2023 |
Abid MB, Estrada-Merly N, Zhang MJ, Chen K, Allan D, Bredeson C, Sabloff M, Guru Murthy GS, Badar T, Hashmi S, Aljurf M, Litzow MR, Kebriaei P, Hourigan CS, Saber W. Impact of Donor Age on Allogeneic Hematopoietic Cell Transplantation Outcomes in Older Adults with Acute Myeloid Leukemia. Transplantation and Cellular Therapy. PMID 37406882 DOI: 10.1016/j.jtct.2023.06.020 |
0.356 |
|
| 2023 |
Boyiadzis M, Zhang MJ, Chen K, Abdel-Azim H, Abid MB, Aljurf M, Bacher U, Badar T, Badawy SM, Battiwalla M, Bejanyan N, Bhatt VR, Brown VI, Castillo P, Cerny J, et al. Correction to: Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113AML patients. Leukemia. PMID 36949156 DOI: 10.1038/s41375-023-01814-2 |
0.373 |
|
| 2023 |
Auletta JJ, Kou J, Chen M, Bolon YT, Broglie L, Bupp C, Christianson D, Cusatis RN, Devine SM, Eapen M, Flynn KE, Hamadani M, Hengen M, Lee SJ, Moskop A, ... ... Zhang MJ, et al. Real-world data showing trends and outcomes by race and ethnicity in allogeneic hematopoietic cell transplantation: a report from the Center for International Blood and Marrow Transplant Research. Transplantation and Cellular Therapy. PMID 36924931 DOI: 10.1016/j.jtct.2023.03.007 |
0.369 |
|
| 2022 |
Mussetti A, Kanate AS, Wang T, He M, Hamadani M, Sr HF, Boumendil A, Glass B, Castagna L, Dominietto A, McGuirk J, Blaise D, Gülbas Z, Diez-Martin J, Marsh SGE, ... ... Zhang MJ, et al. Haploidentical versus matched unrelated donor transplants using post-transplant cyclophosphamide for lymphomas. Transplantation and Cellular Therapy. PMID 36577482 DOI: 10.1016/j.jtct.2022.11.028 |
0.371 |
|
| 2022 |
Boyiadzis M, Zhang MJ, Chen K, Abdel-Azim H, Abid MB, Aljurf M, Bacher U, Badar T, Badawy SM, Battiwalla M, Bejanyan N, Bhatt VR, Brown VI, Castillo P, Cerny J, et al. Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113 AML patients. Leukemia. PMID 36310182 DOI: 10.1038/s41375-022-01738-3 |
0.321 |
|
| 2022 |
Gale RP, Zhang MJ. Statistical challenges in haematopoietic cell transplantation. Bone Marrow Transplantation. PMID 35835998 DOI: 10.1038/s41409-022-01753-z |
0.328 |
|
| 2022 |
Maakaron JE, Zhang MJ, Chen K, Abhyankar S, Bhatt VR, Chhabra S, El Jurdi N, Farag SS, He F, Juckett M, de Lima M, Majhail N, van der Poel M, Saad A, Savani B, et al. Age is no barrier for adults undergoing HCT for AML in CR1: contemporary CIBMTR analysis. Bone Marrow Transplantation. PMID 35368040 DOI: 10.1038/s41409-022-01650-5 |
0.356 |
|
| 2022 |
Jimenez Jimenez AM, De Lima M, Komanduri KV, Wang TP, Zhang MJ, Chen K, Abdel-Azim H, Abid MB, Aljurf M, Alkhateeb H, Assal A, Bacher U, Baron F, Battiwalla M, Beitinjaneh A, et al. Correction to: An adapted European LeukemiaNet genetic risk stratification for acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplant. A CIBMTR analysis. Bone Marrow Transplantation. PMID 35297406 DOI: 10.1038/s41409-022-01625-6 |
0.343 |
|
| 2021 |
Chhabra S, Visotcky A, Pasquini MC, Zhu F, Tang X, Zhang MJ, Thompson R, Abedin S, D'Souza A, Dhakal B, Drobyski WR, Fenske TS, Jerkins JH, Rizzo JD, Runaas L, et al. Corrigendum to 'Ixazomib for chronic Graft-Versus-Host Disease prophylaxis following allogeneic hematopoietic cell transplantation' [Biology of Blood and Marrow Transplantation 26/10 (2020) 1876-1885]. Transplantation and Cellular Therapy. 28: 717. PMID 36202527 DOI: 10.1016/j.jtct.2021.01.005 |
0.354 |
|
| 2021 |
O'Donnell PV, Brunstein CG, Fuchs EJ, Zhang MJ, Allbee-Johnson M, Antin JH, Leifer ES, Elmariah H, Grunwald MR, Hashmi H, Horowitz MM, Magenau JM, Majhail N, Milano F, Morris LE, et al. Umbilical cord blood or HLA-haploidentical transplantation: Real world outcomes vs randomized trial outcomes. Transplantation and Cellular Therapy. PMID 34775146 DOI: 10.1016/j.jtct.2021.11.002 |
0.357 |
|
| 2021 |
Jimenez Jimenez AM, De Lima M, Komanduri KV, Wang TP, Zhang MJ, Chen K, Abdel-Azim H, Abid MB, Aljurf M, Alkhateeb H, Assal A, Bacher U, Baron F, Battiwalla M, Beitinjaneh A, et al. An adapted European LeukemiaNet genetic risk stratification for acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplant. A CIBMTR analysis. Bone Marrow Transplantation. PMID 34584240 DOI: 10.1038/s41409-021-01450-3 |
0.427 |
|
| 2021 |
Menghrajani K, Gomez-Arteaga A, Madero-Marroquin R, Zhang MJ, Bo-Subait K, Sanchez J, Wang HL, Aljurf M, Assal A, Bacher U, Badawy SM, Bejanyan N, Bhatt VR, Bredeson CN, Byrne M, et al. Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AML. Blood Advances. PMID 34551064 DOI: 10.1182/bloodadvances.2021004881 |
0.3 |
|
| 2021 |
Wieduwilt MJ, Metheny L, Zhang MJ, Wang HL, Estrada-Merly N, Marks DI, Al-Homsi AS, Muffly L, Chao NJ, Rizzieri D, Gale RP, Gadalla SM, Cairo MS, Mussetti A, Gore SD, et al. Haploidentical vs. sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia. Blood Advances. PMID 34547770 DOI: 10.1182/bloodadvances.2021004916 |
0.393 |
|
| 2021 |
Orfali N, Zhang MJ, Allbee-Johnson M, Boelens JJ, Artz AS, Brunstein CG, McNiece IK, Milano F, Abid MB, Chee L, Diaz MA, Grunwald MR, Hematti P, Hsu J, Lazarus HM, et al. Planned granulocyte-colony stimulating factor adversely impacts survival after allogeneic hematopoietic cell transplantation performed with Thymoglobulin for myeloid malignancy. Transplantation and Cellular Therapy. PMID 34507002 DOI: 10.1016/j.jtct.2021.08.031 |
0.344 |
|
| 2021 |
Wagner JE, Ballen KK, Zhang MJ, Allbee-Johnson M, Karanes C, Milano F, Verneris MR, Eapen M, Brunstein CG. Comparison of haploidentical and umbilical cord blood transplantation after myeloablative conditioning. Blood Advances. PMID 34461630 DOI: 10.1182/bloodadvances.2021004462 |
0.432 |
|
| 2021 |
Lazaryan A, Dolan M, Zhang MJ, Wang HL, Kharfan-Dabaja MA, Marks DI, Bejanyan N, Copelan E, Majhail NS, Waller EK, Chao N, Prestidge T, Nishihori T, Kebriaei P, Inamoto Y, et al. Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a study by the Acute Leukemia Working Committee of the Center for International Blood and Marrow Transplant Research. Haematologica. 106: 2295-2296. PMID 34333962 DOI: 10.3324/haematol.2021.279046 |
0.344 |
|
| 2021 |
Saber W, Steinert P, Zhang MJ, Chen M, Pope A, Keating A, Wingard JR, Ballen K, Stiff P, Perales MA, Forman S, Champlin R, Langston A, Rudebeck M, Horowitz M. A prospective cohort study comparing long-term outcomes with and without palifermin in patients receiving hematopoietic cell transplantation for hematologic malignancies. Transplantation and Cellular Therapy. PMID 34224914 DOI: 10.1016/j.jtct.2021.06.028 |
0.334 |
|
| 2021 |
Percival ME, Wang HL, Zhang MJ, Saber W, de Lima M, Litzow M, Kebriaei P, Abdel-Azim H, Adekola K, Aljurf M, Bacher U, Badawy SM, Beitinjaneh A, Bejanyan N, Bhatt V, et al. Correction to: Impact of depth of clinical response on outcomes of acute myeloid leukemia patients in first complete remission who undergo allogeneic hematopoietic cell transplantation. Bone Marrow Transplantation. PMID 34017072 DOI: 10.1038/s41409-021-01353-3 |
0.347 |
|
| 2021 |
Duncan C, St Martin A, Pérez WS, Steinert P, Zhang MJ, Chirnomas D, Hoang CJ, Loberiza FR, Saber W. Veno-occlusive disease risk in pediatric patients with acute myeloid leukemia treated with gemtuzumab ozogamicin before allogeneic hematopoietic cell transplantation. Pediatric Blood & Cancer. e29067. PMID 33871892 DOI: 10.1002/pbc.29067 |
0.362 |
|
| 2021 |
Percival ME, Wang HL, Zhang MJ, Saber W, de Lima M, Litzow M, Kebriaei P, Abdel-Azim H, Adekola K, Aljurf M, Bacher U, Badawy SM, Beitinjaneh A, Bejanyan N, Bhatt V, et al. Impact of depth of clinical response on outcomes of acute myeloid leukemia patients in first complete remission who undergo allogeneic hematopoietic cell transplantation. Bone Marrow Transplantation. PMID 33864019 DOI: 10.1038/s41409-021-01261-6 |
0.402 |
|
| 2021 |
Wieduwilt MJ, Stock W, Advani A, Luger S, Larson RA, Tallman M, Appelbaum F, Zhang MJ, Bo-Subait K, Wang HL, Bhatt VR, Dholaria B, Eapen M, Hamadani M, Jamy O, et al. Superior survival with pediatric-style chemotherapy compared to myeloablative allogeneic hematopoietic cell transplantation in older adolescents and young adults with Ph-negative acute lymphoblastic leukemia in first complete remission: analysis from CALGB 10403 and the CIBMTR. Leukemia. PMID 33785862 DOI: 10.1038/s41375-021-01213-5 |
0.335 |
|
| 2021 |
Grunwald MR, Zhang MJ, Elmariah H, Johnson MH, St Martin A, Bashey A, Battiwalla M, Bredeson CN, Copelan E, Cutler CS, George BR, Gupta V, Kanakry C, Mehta RS, Milano F, et al. Alternative donor transplantation for myelodysplastic syndromes: haploidentical relative and matched unrelated donors. Blood Advances. 5: 975-983. PMID 33576783 DOI: 10.1182/bloodadvances.2020003654 |
0.412 |
|
| 2020 |
Hagen P, D'Souza A, Hari P, Davila O, Zhang MJ, Vesole DH, Smith SE, Rodriguez TE, Stiff PJ. Busulfan, melphalan, and bortezomib compared to melphalan as a high dose regimen for autologous hematopoietic stem cell transplantation in multiple myeloma: long term follow up of a novel high dose regimen. Leukemia & Lymphoma. 1-9. PMID 32865474 DOI: 10.1080/10428194.2020.1811275 |
0.403 |
|
| 2020 |
Zhou Z, Nath R, Cerny J, Wang HL, Zhang MJ, Abdel-Azim H, Agrawal V, Ahmed G, Al-Homsi AS, Aljurf M, Alkhateeb HB, Assal A, Bacher U, Bajel A, Bashir Q, et al. Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report. Blood Advances. 4: 3180-3190. PMID 32663298 DOI: 10.1182/Bloodadvances.2019001266 |
0.541 |
|
| 2020 |
Chhabra S, Visotcky A, Pasquini MC, Zhu F, Tang X, Zhang MJ, Thompson R, Abedin S, D'Souza A, Dhakal B, Drobyski WR, Fenske TS, Jerkins JH, Douglas Rizzo J, Runaas L, et al. Ixazomib for chronic Graft-Versus-Host Disease prophylaxis following allogeneic hematopoietic cell transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 32653622 DOI: 10.1016/J.Bbmt.2020.07.005 |
0.477 |
|
| 2020 |
Solomon SR, Martin AS, Zhang MJ, Ballen K, Bashey A, Battiwalla M, Baxter-Lowe LA, Brunstein C, Chhabra S, Perez MAD, Fuchs EJ, Ganguly S, Hardy N, Hematti P, McGuirk J, et al. Optimal donor for African Americans with hematologic malignancy: HLA-haploidentical relative or umbilical cord blood transplant. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 32649981 DOI: 10.1016/j.bbmt.2020.06.029 |
0.387 |
|
| 2020 |
Eapen M, Zhang MJ, Tang XY, Lee SJ, Fei MW, Wang HL, Hebert KM, Arora M, Chhabra S, Devine SM, Hamadani M, D'Souza A, Pasquini MC, Phelan R, Rizzo JD, et al. Hematopoietic cell transplantation with cryopreserved grafts for severe aplastic anemia. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 32389803 DOI: 10.1016/j.bbmt.2020.04.027 |
0.395 |
|
| 2020 |
Hamadani M, Zhang MJ, Tang XY, Fei M, Brunstein C, Chhabra S, D'Souza A, Milano F, Phelan R, Saber W, Shaw BE, Weisdorf D, Devine SM, Horowitz MM. Graft cryopreservation does not impact overall survival allogeneic hematopoietic cell transplantation using post-transplant cyclophosphamide for GVHD prophylaxis. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 32283185 DOI: 10.1016/j.bbmt.2020.04.001 |
0.379 |
|
| 2020 |
Fatobene G, Rocha V, St Martin A, Hamadani M, Robinson S, Bashey A, Boumendil A, Brunstein C, Castagna L, Dominietto A, Finel H, Chalandon Y, Kenzey C, Kharfan-Dabaja M, Labussière-Wallet H, ... ... Zhang MJ, et al. Nonmyeloablative Alternative Donor Transplantation for Hodgkin and Non-Hodgkin Lymphoma: From the LWP-EBMT, Eurocord, and CIBMTR. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1902408. PMID 32031876 DOI: 10.1200/JCO.19.02408 |
0.366 |
|
| 2020 |
Wagner JE, Ballen KK, Zhang M, Johnson MH, Karanas C, Milano F, Verneris MR, Eapen M. Comparison of Haploidentical Related Donor with Post-Transplant Cyclophosphamide (PTCy) and Umbilical Cord Blood (UCB) Transplantation after Myeloablative Conditioning for Hematological Malignancy Biology of Blood and Marrow Transplantation. 26. DOI: 10.1016/J.Bbmt.2019.12.566 |
0.508 |
|
| 2020 |
Menghrajani K, Zhang M, Bo-Subait K, Wang H, Devlin SM, Madero-Marroquin R, Arteaga AG, Sandmaier BM, Litzow MR, Kebriaei P, Weisdorf DJ, Zhang Y, Tallman M, Saber W. MLL-Rearranged AML Is Associated with Poor Outcomes As Compared to Patients with Intermediate- and Adverse-Risk Disease: A CIBMTR Study of 3779 Adult Patients Biology of Blood and Marrow Transplantation. 26. DOI: 10.1016/J.Bbmt.2019.12.074 |
0.431 |
|
| 2019 |
Ho VT, Martin AS, Pérez WS, Steinert P, Zhang MJ, Chirnomas D, Hoang CJ, Loberiza FR, Saber W. Prior Gemtuzumab Ozogamicin Exposure in Adults With Acute Myeloid Leukemia Does Not Increase Hepatic Veno-occlusive Disease Risk After Allogeneic Hematopoietic Cell Transplantation: A CIBMTR Analysis. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 31891815 DOI: 10.1016/J.Bbmt.2019.12.763 |
0.5 |
|
| 2019 |
Solomon SR, St Martin A, Shah NN, Fatobene G, Al Malki MM, Ballen KK, Bashey A, Bejanyan N, Bolaños Meade J, Brunstein CG, DeFilipp Z, Champlin RE, Fuchs EJ, Hamadani M, Hematti P, ... ... Zhang MJ, et al. Myeloablative vs reduced intensity T-cell-replete haploidentical transplantation for hematologic malignancy. Blood Advances. 3: 2836-2844. PMID 31582392 DOI: 10.1182/bloodadvances.2019000627 |
0.402 |
|
| 2019 |
Lazaryan A, Dolan M, Zhang MJ, Wang HL, Kharfan-Dabaja MA, Marks DI, Bejanyan N, Copelan E, Maijhail N, Waller EK, Chao N, Prestidge T, Nishihori T, Kebriaei P, Inamoto Y, et al. Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a study by the Acute Leukemia Working Committee of the Center for International Blood and Marrow Transplant Research. Haematologica. PMID 31558669 DOI: 10.3324/Haematol.2019.220756 |
0.513 |
|
| 2019 |
Rashidi A, Hamadani M, Zhang MJ, Wang HL, Abdel-Azim H, Aljurf M, Assal A, Bajel A, Bashey A, Battiwalla M, Beitinjaneh AM, Bejanyan N, Bhatt VR, Bolaños-Meade J, Byrne M, et al. Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission. Blood Advances. 3: 1826-1836. PMID 31201170 DOI: 10.1182/Bloodadvances.2019000050 |
0.421 |
|
| 2019 |
Hu ZH, Peter Gale R, Zhang MJ. Direct adjusted survival and cumulative incidence curves for observational studies. Bone Marrow Transplantation. PMID 31101889 DOI: 10.1038/S41409-019-0552-Y |
0.483 |
|
| 2019 |
Perales MA, Tomlinson B, Zhang MJ, St Martin A, Beitinjaneh A, Gibson J, Hogan W, Kekre N, Lazarus H, Marks D, McGuirk J, Romee R, Solh M, Wagner JE, Weisdorf DJ, et al. Alternative donor transplantation for acute myeloid leukemia in patients aged ≥50 years: young HLA-matched unrelated or haploidentical Donor? Haematologica. PMID 31101756 DOI: 10.3324/haematol.2018.215202 |
0.427 |
|
| 2019 |
Ustun C, Le-Rademacher J, Wang HL, Othus M, Sun Z, Major B, Zhang MJ, Storrick E, Lafky JM, Chow S, Mrózek K, Attar EC, Nand S, Bloomfield CD, Cripe LD, et al. Allogeneic hematopoietic cell transplantation compared to chemotherapy consolidation in older acute myeloid leukemia (AML) patients 60-75 years in first complete remission (CR1): an alliance (A151509), SWOG, ECOG-ACRIN, and CIBMTR study. Leukemia. PMID 31073153 DOI: 10.1038/S41375-019-0477-X |
0.373 |
|
| 2019 |
Gale RP, Zhang MJ. Statistical analyses of clinical trials in haematopoietic cell transplantation or why there is a strong correlation between people drowning after falling out of a fishing boat and marriage rate in Kentucky. Bone Marrow Transplantation. PMID 30914755 DOI: 10.1038/S41409-019-0431-6 |
0.365 |
|
| 2019 |
Yeshurun M, Weisdorf D, Rowe JM, Tallman MS, Zhang MJ, Wang HL, Saber W, de Lima M, Sandmaier BM, Uy G, Kamble RT, Cairo MS, Cooper BW, Cahn JY, Ganguly S, et al. The impact of the graft-versus-leukemia effect on survival in acute lymphoblastic leukemia. Blood Advances. 3: 670-680. PMID 30808685 DOI: 10.1182/bloodadvances.2018027003 |
0.36 |
|
| 2019 |
Wieduwilt MJ, Stock W, Advani AS, Luger SM, Larson RA, Tallman MS, Appelbaum FR, Zhang M, Bo-Subait K, Sandmaier BM, Lima Md, Kebriaei P, Litzow M, Saber W, Weisdorf DJ. Superior Survival with Post-Remission Pediatric-Inspired Chemotherapy Compared to Myeloablative Allogeneic Hematopoietic Cell Transplantation in Adolescents and Young Adults with Ph-Negative Acute Lymphoblastic Leukemia in First Complete Remission: Comparison of CALGB 10403 to Patients Reported to the CIBMTR Blood. 134: 261-261. DOI: 10.1182/Blood-2019-128560 |
0.436 |
|
| 2019 |
Metheny L, Saber W, Weisdorf DJ, Lima Md, Callander NS, Litzow M, Kebriaei P, Hall AC, Sandmaier BM, Zhang M, Wang H, Bo-Subait K. Allogeneic Hematopoietic Stem Cell Transplantation for Therapy-Related Myelodysplastic Syndromes and Acute Myeloid Leukemia Blood. 134: 2036-2036. DOI: 10.1182/Blood-2019-125946 |
0.406 |
|
| 2019 |
Grunwald MR, Zhang M, Elmariah H, Johnson MH, Martin AS, Bashey A, Bolanos-Meade J, Bredeson C, Copelan EA, George B, Gupta V, Kanakry CG, Mehta RS, Battiwalla M, Mussetti A, et al. Allogeneic Transplantation for Myelodysplastic Syndrome in Adults over 50 Years Old Using Reduced Intensity/Non-Myeloablative Conditioning: Haploidentical Relative Versus Matched Unrelated Donor Blood. 134: 3323-3323. DOI: 10.1182/Blood-2019-125865 |
0.421 |
|
| 2019 |
Hagen P, D'Souza A, Hari P, Davila O, Zhang M, Vesole DH, Smith SE, Rodriguez TE, Stiff PJ. Busulfan, Melphalan, and Bortezomib Compared to Single Agent High-Dose Melphalan As a Conditioning Regimen for Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma: Long Term Follow up of a Novel Conditioning Regimen Blood. 134: 2023-2023. DOI: 10.1182/Blood-2019-124188 |
0.401 |
|
| 2019 |
Bejanyan N, Zhang M, Bo-Subait K, Wang H, Warlick ED, Brunstein CG, Sandmaier BM, Litzow M, Kebriaei P, Saber W, Weisdorf DJ. Myeloablative Conditioning Is Preferred for Allogeneic Transplantation of Acute Myeloid Leukemia and Myelodysplastic Syndromes with Low/Intermediate but Not High Disease Risk Index Blood. 134: 4603-4603. DOI: 10.1182/Blood-2019-123513 |
0.419 |
|
| 2019 |
Percival MM, Wang H, Zhang M, Estey EH, Litzow M, Kebriaei P, Lima Md, Saber W, Weisdorf DJ, Sandmaier BM. Impact of Depth of Pretransplant Clinical Response on Outcomes of Acute Myeloid Leukemia Patients in First Complete Remission (AML-CR1) Who Undergo Allogeneic Hematopoietic Cell Transplantation (AlloHCT) Blood. 134: 4585-4585. DOI: 10.1182/Blood-2019-123510 |
0.447 |
|
| 2019 |
Rashidi A, Hamadani M, Wang H, Bolanos J, Lee JW, Ciurea SO, Holland HK, Koc Y, Maertens JA, Stockerl-Goldstein K, Bashey A, Aljurf M, Cutler C, Nakamura R, Oran B, ... ... Zhang M, et al. HLA-Matched Sibling Versus Haploidentical Hematopoietic Cell Transplantation (HCT) in Patients with Acute Myeloid Leukemia (AML) in First Complete Remission (CR1) Biology of Blood and Marrow Transplantation. 25. DOI: 10.1016/J.Bbmt.2018.12.138 |
0.487 |
|
| 2018 |
Keesler DA, Martin AS, Bonfim C, Seber A, Zhang MJ, Eapen M. Bone Marrow versus Peripheral Blood from Unrelated Donors for Children and Adolescents with Acute Leukemia. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 30142417 DOI: 10.1016/J.Bbmt.2018.08.010 |
0.48 |
|
| 2018 |
Strouse C, Zhang Y, Zhang MJ, DiGilio A, Pasquini M, Horowitz MM, Lee S, Ho V, Ramanathan M, Chinratanalab W, Loren A, Burns LJ, Artz A, Villa KF, Saber W. "Risk Score for Development of Veno-Occlusive Disease After Allogeneic Hematopoietic Cell Transplant". Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 29928989 DOI: 10.1016/J.Bbmt.2018.06.013 |
0.436 |
|
| 2018 |
Robinson TM, Fuchs EJ, Zhang MJ, St Martin A, Labopin M, Keesler DA, Blaise D, Bashey A, Bourhis JH, Ciceri F, Ciurea SO, Devine SM, Mohty M, McCurdy SR, Milpied N, et al. Related donor transplants: has posttransplantation cyclophosphamide nullified the detrimental effect of HLA mismatch? Blood Advances. 2: 1180-1186. PMID 29794073 DOI: 10.1182/Bloodadvances.2018018291 |
0.502 |
|
| 2018 |
Moodie EEM, Stephens DA, Alam S, Zhang MJ, Logan B, Arora M, Spellman S, Krakow EF. A cure-rate model for Q-learning: Estimating an adaptive immunosuppressant treatment strategy for allogeneic hematopoietic cell transplant patients. Biometrical Journal. Biometrische Zeitschrift. PMID 29766558 DOI: 10.1002/Bimj.201700181 |
0.327 |
|
| 2018 |
McCurdy SR, Zhang MJ, St Martin A, Al Malki MM, Bashey A, Gaballa S, Keesler DA, Hamadani M, Norkin M, Perales MA, Reshef R, Rocha V, Romee R, Solh M, Urbano-Ispizua A, et al. Effect of donor characteristics on haploidentical transplantation with posttransplantation cyclophosphamide. Blood Advances. 2: 299-307. PMID 29440002 DOI: 10.1182/bloodadvances.2017014829 |
0.395 |
|
| 2018 |
Sureda A, Zhang MJ, Dreger P, Carreras J, Fenske T, Finel H, Schouten H, Montoto S, Robinson S, Smith SM, Boumedil A, Hamadani M, Pasquini MC. Allogeneic hematopoietic stem cell transplantation for relapsed follicular lymphoma: A combined analysis on behalf of the Lymphoma Working Party of the EBMT and the Lymphoma Committee of the CIBMTR. Cancer. PMID 29424927 DOI: 10.1002/cncr.31264 |
0.356 |
|
| 2018 |
Ustun C, Le-Rademacher J, Wang H, Othus M, Sun Z, Major B, Zhang M, Storrick E, Lafky JM, Chow S, Mrózek K, Attar EC, Bloomfield CD, Cripe LD, Larson RA, et al. Allogeneic Hematopoietic Cell Transplantation (HCT) Vs. Non-HCT Consolidation Therapies in Acute Myeloid Leukemia (AML) Patients 60-75 Years of Age in First Complete Remission (CR1): An Alliance (A151509), SWOG, ECOG-ACRIN and CIBMTR Study Blood. 132: 2170-2170. DOI: 10.1182/Blood-2018-99-118383 |
0.394 |
|
| 2018 |
Solomon SR, Martin AS, Shah NN, Fatobene G, Malki MA, Ballen KK, Bashey A, Bejanyan N, Bolaños-Meade J, Brunstein CG, Defilipp Z, Champlin RE, Fuchs EJ, Hamadani M, Hematti P, ... ... Zhang M, et al. T-Replete Haploidentical Cell Transplantation Using Post-Transplant Cyclophosphamide for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome: Effect of Transplant Conditioning Regimen Intensity on Outcomes Blood. 132: 1015-1015. DOI: 10.1182/Blood-2018-99-110814 |
0.485 |
|
| 2018 |
Duncan C, Martin AS, Perez W, Steinert P, Zhang M, Chirnomas D, Hoang CJ, Loberiza FR, Saber W. Veno-Occlusive Disease Characteristics in Pediatric Patients with Acute Myeloid Leukemia Receiving Gemtuzumab Ozogamicin before Allogeneic Stem Cell Transplant Biology of Blood and Marrow Transplantation. 24. DOI: 10.1016/J.Bbmt.2017.12.347 |
0.46 |
|
| 2018 |
Ho VT, Martin AS, Perez W, Steinert P, Zhang M, Chirnomas D, Hoang CJ, Loberiza FR, Saber W. Characterization of Veno-Occlusive Disease (VOD) in Adult Patients (Pts) with Acute Myeloid Leukemia (AML) Receiving Gemtuzumab Ozogamicin (GO) before Allogeneic Stem Cell Transplant (SCT) Biology of Blood and Marrow Transplantation. 24. DOI: 10.1016/J.Bbmt.2017.12.346 |
0.446 |
|
| 2017 |
Bejanyan N, Zhang MJ, Wang HL, Lazaryan A, de Lima M, Marks DI, Sandmaier BM, Bachanova V, Rowe J, Tallman M, Kebriaei P, Kharfan-Dabaja M, Gale RP, Lazarus HM, Ustun C, et al. Pre-Transplant Consolidation is Not Beneficial for Adults with ALL Undergoing Myeloablative Allogeneic Transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 29275139 DOI: 10.1016/j.bbmt.2017.12.784 |
0.412 |
|
| 2017 |
Kebriaei P, Anasetti C, Zhang MJ, Wang HL, Aldoss I, de Lima M, Khoury HJ, Sandmaier BM, Horowitz MM, Artz A, Bejanyan N, Ciurea S, Lazarus HM, Gale RP, Litzow M, et al. Intravenous Busulfan Compared with Total Body Irradiation Pretransplant Conditioning for Adults with Acute Lymphoblastic Leukemia. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 29197676 DOI: 10.1016/J.Bbmt.2017.11.025 |
0.505 |
|
| 2017 |
Htut M, D'Souza A, Krishnan A, Bruno B, Zhang MJ, Fei M, Diaz MA, Copelan E, Ganguly S, Hamadani M, Kharfan-Dabaja M, Lazarus H, Lee C, Meehan K, Nishihori T, et al. Autologous/Allogeneic Hematopoietic Cell Transplantation (HCT) Versus Tandem Autologous Transplantation for Multiple Myeloma - Comparison of Long Term Post Relapse Survival. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 29079457 DOI: 10.1016/j.bbmt.2017.10.024 |
0.428 |
|
| 2017 |
Bashey A, Zhang MJ, McCurdy SR, St Martin A, Argall T, Anasetti C, Ciurea SO, Fasan O, Gaballa S, Hamadani M, Munshi P, Al Malki MM, Nakamura R, O'Donnell PV, Perales MA, et al. Mobilized Peripheral Blood Stem Cells Versus Unstimulated Bone Marrow As a Graft Source for T-Cell-Replete Haploidentical Donor Transplantation Using Post-Transplant Cyclophosphamide. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2017728428. PMID 28644773 DOI: 10.1200/JCO.2017.72.8428 |
0.428 |
|
| 2017 |
Cheng YC, Shi Y, Zhang MJ, Brazauskas R, Hemmer MT, Bishop MR, Nieto Y, Stadtmauer E, Ayash L, Gale RP, Lazarus H, Holmberg L, Lill M, Olsson RF, Wirk BM, et al. Long-Term Outcome of Inflammatory Breast Cancer Compared to Non-Inflammatory Breast Cancer in the Setting of High-Dose Chemotherapy with Autologous Hematopoietic Cell Transplantation. Journal of Cancer. 8: 1009-1017. PMID 28529613 DOI: 10.7150/jca.16870 |
0.359 |
|
| 2017 |
Kekre N, Zhang Y, Zhang MJ, Carreras J, Ahmed P, Anderlini P, Atta EH, Ayas M, Boelens JJ, Bonfim C, Deeg HJ, Kapoor N, Lee JW, Nakamura R, Pulsipher MA, et al. Effect of antithymocyte globulin source on outcomes of bone marrow transplantation for severe aplastic anemia. Haematologica. PMID 28341733 DOI: 10.3324/haematol.2017.164459 |
0.403 |
|
| 2017 |
Brunstein C, Zhang MJ, Barker J, St Martin A, Bashey A, De Lima M, Dehn J, Hematti P, Perales MA, Rocha V, Territo M, Weisdorf D, Eapen M. The effect of inter-unit HLA matching in double umbilical cord blood transplantation for acute leukemia. Haematologica. PMID 28126967 DOI: 10.3324/haematol.2016.158584 |
0.355 |
|
| 2017 |
Michelis FV, Gupta V, Zhang MJ, Wang HL, Aljurf M, Bacher U, Beitinjaneh A, Chen YB, DeFilipp Z, Gale RP, Kebriaei P, Kharfan-Dabaja M, Lazarus HM, Nishihori T, Olsson RF, et al. Cytogenetic risk determines outcomes after allogeneic transplantation in older patients with acute myeloid leukemia in their second complete remission: A Center for International Blood and Marrow Transplant Research cohort analysis. Cancer. PMID 28117898 DOI: 10.1002/cncr.30567 |
0.398 |
|
| 2017 |
Weisdorf DJ, Millard HR, Horowitz MM, Hyare PS, Champlin R, Ho V, Mielcarek M, Rezvani A, Stockerl-Goldstein K, Khoury HJ, De Lima M, Saber W, Sandmaier B, Zhang MJ, Eapen M. Allogeneic transplantation for advanced acute myeloid leukemia: The value of complete remission. Cancer. PMID 28117884 DOI: 10.1002/cncr.30536 |
0.388 |
|
| 2017 |
Robinson TM, Fuchs EJ, Zhang M, Labopin M, Martin AS, Keesler DA, Blaise D, Bashey A, Bourhis J, Ciceri F, Ciurea SO, Devine SM, Mohty M, McCurdy SR, Milpied N, et al. Selecting between HLA-Matched Siblings and HLA- Haploidentical Related Donors for Acute Leukemia in the Era of Post-Transplant Cyclophosphamide: The Center for International Blood and Marrow Transplant Registry and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplant Blood. 130: 851-851. DOI: 10.1182/Blood.V130.Suppl_1.851.851 |
0.509 |
|
| 2017 |
Lazaryan A, Dolan M, Zhang M, Wang H, Bachanova V, Lima MD, Sandmaier BM, Weisdorf DJ. Prognostic Significance of Cytogenetic Abnormalities in Patients with Philadelphia-Negative ALL Undergoing Allogeneic Hematopoietic Stem Cell Transplantation in Complete Remission: A CIBMTR Analysis Blood. 130: 1439-1439. DOI: 10.1182/Blood.V130.Suppl_1.1439.1439 |
0.462 |
|
| 2017 |
Strouse C, Zhang Y, Zhang M, DiGilio A, Lee SJ, Ramanathan M, Chinratanalab W, Loren AW, Burns LJ, Artz AS, Villa KF, Saber W. Stratification of Allogeneic Hematopoietic Cell Transplant Patients by Risk of Developing Veno-Occlusive Disease: A Model for Assigning a Risk Score Biology of Blood and Marrow Transplantation. 23. DOI: 10.1016/J.Bbmt.2016.12.221 |
0.43 |
|
| 2017 |
Dispenzieri A, Kumar S, Zhang M, Krishnan A, Gasparetto C, Nieto Y, Fraser R, Huang J, Hari P, D'Souza A. Trends in Survival Outcomes Among Patients (pts) Relapsing Early after Autologous Stem Cell Transplantation (ASCT) for Multiple Myeloma (MM) (CIBMTR Study # MM14-03) Biology of Blood and Marrow Transplantation. 23. DOI: 10.1016/J.Bbmt.2016.12.040 |
0.452 |
|
| 2016 |
Cornell RF, D'Souza A, Kassim AA, Costa LJ, Innis-Shelton RD, Zhang MJ, Huang J, Abidi M, Aiello J, Akpek G, Bashey A, Bashir Q, Cerny J, Comenzo R, Diaz MA, et al. Maintenance Versus Induction Therapy Choice on Outcomes after Autologous Transplantation for Multiple Myeloma. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 27864161 DOI: 10.1016/j.bbmt.2016.11.011 |
0.382 |
|
| 2016 |
Beksac M, Gragert L, Fingerson S, Maiers M, Zhang MJ, Albrecht M, Zhong X, Cozen W, Dispenzieri A, Lonial S, Hari P. HLA polymorphism and risk of multiple myeloma. Leukemia. PMID 27461064 DOI: 10.1038/Leu.2016.199 |
0.302 |
|
| 2016 |
Qin YZ, Wang Y, Zhu HH, Gale RP, Zhang MJ, Jiang Q, Jiang H, Xu LP, Chen H, Zhang XH, Liu YR, Lai YY, Jiang B, Liu KY, Huang XJ. Low WT1 transcript levels at diagnosis predicted poor outcomes of acute myeloid leukemia patients with t(8;21) who received chemotherapy or allogeneic hematopoietic stem cell transplantation. Chinese Journal of Cancer. 35: 46. PMID 27197573 DOI: 10.1186/S40880-016-0110-6 |
0.378 |
|
| 2016 |
Dhakal B, D'Souza A, Martens M, Kapke J, Harrington AM, Pasquini M, Saber W, Drobyski WR, Zhang MJ, Hamadani M, Hari PN. Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma: Impact of Disease Risk and Post Allograft Minimal Residual Disease on Survival. Clinical Lymphoma, Myeloma & Leukemia. PMID 27160644 DOI: 10.1016/j.clml.2016.03.001 |
0.412 |
|
| 2016 |
Saber W, Zhang MJ, Steinert P, Chen M, Horowitz MM. The Impact Of Palifermin Use On Hematopoietic Cell Transplant Outcomes In Children. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 27090960 DOI: 10.1016/J.Bbmt.2016.04.008 |
0.421 |
|
| 2016 |
Tan D, Li Q, Zhang MJ, Liu C, Ma C, Zhang P, Ding YH, Fan SB, Tao L, Yang B, Li X, Ma S, Liu J, Feng B, Liu X, et al. Trifunctional cross-linker for mapping protein-protein interaction networks and comparing protein conformational states. Elife. 5. PMID 26952210 DOI: 10.7554/Elife.12509 |
0.301 |
|
| 2016 |
Van Besien K, Hari P, Zhang MJ, Liu HT, Stock W, Godley L, Odenike O, Larson R, Bishop M, Wickrema A, Gergis U, Mayer S, Shore T, Tsai S, Rhodes J, et al. Reduced intensity haplo plus single cord transplant compared to double cord transplant: improved engraftment and survival free of progression and GVHD (GRFS). Haematologica. PMID 26869630 DOI: 10.3324/Haematol.2015.138594 |
0.457 |
|
| 2016 |
Weisdorf DJ, Millard HR, Horowitz MM, Eapen M, Hyare P, Ward R, Khoury HJ, Lima MJGD, Sandmaier BM, Zhang M. Allogeneic transplantation for advanced acute myelogenous leukemia: The value of complete remission. Journal of Clinical Oncology. 34: 7033-7033. DOI: 10.1200/Jco.2016.34.15_Suppl.7033 |
0.476 |
|
| 2016 |
Strouse C, Zhang Y, Zhang M, DiGilio A, Pasquini MC, Horowitz MM, Lee SJ, Ramanathan M, Chinratanalab W, Loren AW, Burns LJ, Artz A, Villa KF, Saber W. Stratification of Allogeneic Hematopoietic Cell Transplant By Risk of Developing Veno-Occlusive Disease: A Model for Assigning a Risk Score Blood. 128: 983-983. DOI: 10.1182/Blood.V128.22.983.983 |
0.41 |
|
| 2016 |
Htut M, D'Souza A, Bruno B, Zhang M, Fei M, Gasparetto C, Nieto Y, Krishnan A, Hari P. Survival after Relapse Following Tandem Allogeneic Vs. Tandem Autologous Hematopoietic Cell Transplantation (HCT) for Myeloma (MM) Blood. 128: 833-833. DOI: 10.1182/Blood.V128.22.833.833 |
0.507 |
|
| 2016 |
Bejanyan N, Lazaryan A, Zhang M, Wang H, Lima Md, Sandmaier BM, Horowitz MM, Khoury HJ, Weisdorf DJ. Consolidation Chemotherapy Is Not Beneficial for Adult Acute Lymphoblastic Leukemia Patients with Available Donor Undergoing Myeloablative Allogeneic Hematopoietic Cell Transplantation in First Complete Remission: A CIBMTR Study Blood. 128: 684-684. DOI: 10.1182/Blood.V128.22.684.684 |
0.515 |
|
| 2016 |
Bashey A, Zhang M, McCurdy SR, Ciurea SO, Martin AS, Anasetti C, Argall T, Fasan OO, Gaballa S, Hamadani M, Malki MMa, Munshi PN, Nakamura R, O'Donnell PV, Perales M, et al. Comparison of Peripheral Blood Stem Cells (PBSC) to Bone Marrow (BM) for T-Replete HLA-Haploidentical Donor Transplantation Using Post-Transplant Cyclophosphamide Blood. 128: 683-683. DOI: 10.1182/Blood.V128.22.683.683 |
0.536 |
|
| 2016 |
Kebriaei P, Anasetti C, Zhang M, Wang H, Aldoss I, Lima Md, Khoury HJ, Sandmaier BM, Horowitz MM, Artz A, Bejanyan N, Ciurea SO, Lazarus HM, Gale RP, Litzow M, et al. Comparison of Total Body Irradiation-Based with Intravenous Busulfan-Based Chemotherapy-Only Conditioning Regimens for Myeloablative Hematopoietic Cell Transplantation (HCT) in Adults with Acute Lymphoblastic Leukemia Blood. 128: 679-679. DOI: 10.1182/Blood.V128.22.679.679 |
0.498 |
|
| 2016 |
Eapen M, Kurtzberg J, Zhang M, Mendizabal AM, Chang KW, Duval M, Fei M, Neudorf S, Oliveira SND, Wall DA, Schultz KR, Horowitz MM, Wagner JE. Umbilical Cord Blood (UCB) Transplantation in Children with Acute Leukemia: Impact of Conditioning Regimen on Transplant Outcomes Blood. 128: 1231-1231. DOI: 10.1182/Blood.V128.22.1231.1231 |
0.473 |
|
| 2015 |
Seftel MD, Neuberg D, Zhang MJ, Wang HL, Ballen KK, Bergeron J, Couban S, Freytes CO, Hamadani M, Kharfan-Dabaja MA, Lazarus HM, Nishihori T, Paulson K, Saber W, Sallan SE, et al. Pediatric-inspired Therapy compared to Allografting for Philadelphia Chromosome Negative Adult ALL in First Complete Remission. American Journal of Hematology. PMID 26701142 DOI: 10.1002/Ajh.24285 |
0.316 |
|
| 2015 |
Kollman C, Spellman SR, Zhang MJ, Hassebroek A, Anasetti C, Antin JH, Champlin RE, Confer DL, DiPersio JF, Fernandez-Viña M, Hartzman RJ, Horowitz MM, Hurley CK, Karanes C, Maiers M, et al. The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy. Blood. PMID 26527675 DOI: 10.1182/Blood-2015-08-663823 |
0.397 |
|
| 2015 |
D'Souza A, Dispenzieri A, Wirk B, Zhang MJ, Huang J, Gertz MA, Kyle RA, Kumar S, Comenzo RL, Peter Gale R, Lazarus HM, Savani BN, Cornell RF, Weiss BM, Vogl DT, et al. Improved Outcomes After Autologous Hematopoietic Cell Transplantation for Light Chain Amyloidosis: A Center for International Blood and Marrow Transplant Research Study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 33: 3741-9. PMID 26371138 DOI: 10.1200/JCO.2015.62.4015 |
0.357 |
|
| 2015 |
Pasquini MC, Zhang MJ, Medeiros BC, Armand P, Hu ZH, Nishihori T, Aljurf MD, Akpek G, Cahn JY, Cairo MS, Cerny J, Copelan EA, Deol A, Freytes CO, Gale RP, et al. Hematopoietic Cell Transplantation Outcomes in Monosomal Karyotype Myeloid Malignancies. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 26327629 DOI: 10.1016/j.bbmt.2015.08.024 |
0.38 |
|
| 2015 |
Ciurea SO, Zhang MJ, Bacigalupo AA, Bashey A, Appelbaum FR, Aljitawi OS, Armand P, Antin JH, Chen J, Devine SM, Fowler DH, Luznik L, Nakamura R, O'Donnell PV, Perales MA, et al. Haploidentical transplant with post-transplant cyclophosphamide versus matched unrelated donor transplant for acute myeloid leukemia. Blood. PMID 26130705 DOI: 10.1182/blood-2015-04-639831 |
0.418 |
|
| 2015 |
Eriksson F, Li J, Scheike T, Zhang MJ. The proportional odds cumulative incidence model for competing risks. Biometrics. 71: 687-95. PMID 26013050 DOI: 10.1111/Biom.12330 |
0.346 |
|
| 2015 |
Urbano-Ispizua A, Pavletic SZ, Flowers ME, Klein JP, Zhang MJ, Carreras J, Montoto S, Perales MA, Aljurf MD, Akpek G, Bredeson CN, Costa LJ, Dandoy C, Freytes CO, Fung HC, et al. The Impact of Graft-versus-Host Disease on the Relapse Rate in Patients with Lymphoma Depends on the Histological Subtype and the Intensity of the Conditioning Regimen. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 25981509 DOI: 10.1016/J.Bbmt.2015.05.010 |
0.506 |
|
| 2015 |
Mehta PA, Zhang MJ, Eapen M, He W, Seber A, Gibson B, Camitta BM, Kitko CL, Dvorak CC, Nemecek ER, Frangoul HA, Abdel-Azim H, Kasow KA, Lehmann L, Gonzalez Vicent M, et al. Transplantation Outcomes for Children with Hypodiploid Acute Lymphoblastic Leukemia. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 21: 1273-7. PMID 25865650 DOI: 10.1016/j.bbmt.2015.04.008 |
0.429 |
|
| 2015 |
Holter-Chakrabarty JL, Pierson N, Zhang MJ, Zhu X, Akpek G, Aljurf MD, Artz AS, Baron F, Bredeson CN, Dvorak CC, Epstein RB, Lazarus HM, Olsson RF, Selby GB, Williams KM, et al. The Sequence of Cyclophosphamide and Myeloablative Total Body Irradiation in Hematopoietic Cell Transplantation for Patients with Acute Leukemia. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 21: 1251-7. PMID 25840335 DOI: 10.1016/J.Bbmt.2015.03.017 |
0.494 |
|
| 2015 |
Logan AC, Wang Z, Alimoghaddam K, Wong RM, Lai T, Negrin RS, Grumet C, Logan BR, Zhang MJ, Spellman SR, Lee SJ, Miklos DB. ABO mismatch is associated with increased nonrelapse mortality after allogeneic hematopoietic cell transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 21: 746-54. PMID 25572032 DOI: 10.1016/J.Bbmt.2014.12.036 |
0.427 |
|
| 2015 |
Bejanyan N, Weisdorf DJ, Logan BR, Wang HL, Devine SM, de Lima M, Bunjes DW, Zhang MJ. Survival of patients with acute myeloid leukemia relapsing after allogeneic hematopoietic cell transplantation: a center for international blood and marrow transplant research study. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 21: 454-9. PMID 25460355 DOI: 10.1016/J.Bbmt.2014.11.007 |
0.41 |
|
| 2015 |
Vij R, Kumar S, Zhang MJ, Zhong X, Huang J, Dispenzieri A, Abidi MH, Bird JM, Freytes CO, Gale RP, Kindwall-Keller TL, Kyle RA, Landsburg DJ, Lazarus HM, Munker R, et al. Impact of pretransplant therapy and depth of disease response before autologous transplantation for multiple myeloma. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 21: 335-41. PMID 25445028 DOI: 10.1016/j.bbmt.2014.10.023 |
0.309 |
|
| 2015 |
Ganzel C, Mathews V, Alimoghaddam K, Ghavamzadeh A, Kuk D, Devlin S, Wang H, Weisdorf D, Douer D, Rowe JM, Nagler A, Mohty M, Tallman MS, Estev J, Zhang M. Autologous Transplant, and Not ATO Alone, Remains the Preferred Therapy for Relapsed APL: A Report from the CIBMTR, EBMT and Two Specialized Centers Blood. 126: 928-928. DOI: 10.1182/Blood.V126.23.928.928 |
0.519 |
|
| 2015 |
Cornell RF, Costa LJ, Kassim AA, Inns-Shelton R, Krishnan A, Mark T, Nieto Y, Gasparetto CJ, D'Souza A, Hari P, Zhang M, Huang J. Post-Transplant Therapy Is More Important Than Induction Regimen Choice in Autologous Hematopoietic Cell Transplantation (AHCT) Recipients for Multiple Myeloma (MM) Blood. 126: 396-396. DOI: 10.1182/Blood.V126.23.396.396 |
0.509 |
|
| 2015 |
Michelis FV, Gupta V, Zhang M, Wang H, Lima Md, Khoury HJ, Sandmaier BM, Saber W. Outcomes of Allogeneic Transplantation in Patients Aged ≤ 60 Years with Acute Myeloid Leukemia in Second Complete Remission: A CIBMTR ® Cohort Analysis Blood. 126: 2009-2009. DOI: 10.1182/Blood.V126.23.2009.2009 |
0.51 |
|
| 2015 |
Sureda A, Zhang M, Dreger P, Carreras J, Fenske TS, Finel H, Schouten HC, Montoto S, Robinson S, Smith SM, Boumendil A, Hamadani M, Pasquini MC. Allogeneic Stem Cell Transplantation for Relapsed / Refractory (R/R) Follicular Lymphoma (FL). a Joint Study Between the European Society for Blood and Marrow Transplantation (EBMT) and the Center for International Blood and Marrow Transplant Research (CIBMTR) Blood. 126: 198-198. DOI: 10.1182/Blood.V126.23.198.198 |
0.496 |
|
| 2015 |
Dhakal B, Martens M, Kapke J, D'Souza A, Pasquini MC, Saber W, Hamadani M, Drobyski W, Rizzo JD, Horowitz MM, Zhang M, Hari PN. Outcomes of Allogeneic Hematopoietic Cell Transplantation (AHCT) for Multiple Myeloma (MM): Impact of Disease Risk and Conditioning Regimen Biology of Blood and Marrow Transplantation. 21. DOI: 10.1016/J.Bbmt.2014.11.441 |
0.45 |
|
| 2014 |
Liu DM, Lu N, Zhao L, Zhang MJ, Tao B, Xuan Y, Sun LH, Zhao HY, Wang WQ, Liu JM, Ning G. Serum Sema3A is in a weak positive association with bone formation marker osteocalcin but not related to bone mineral densities in postmenopausal women. The Journal of Clinical Endocrinology and Metabolism. 99: E2504-9. PMID 25050899 DOI: 10.1210/jc.2014-1443 |
0.327 |
|
| 2014 |
Sharma M, Zhang MJ, Zhong X, Abidi MH, Akpek G, Bacher U, Callander NS, Dispenzieri A, Freytes CO, Fung HC, Gale RP, Gasparetto C, Gibson J, Holmberg LA, Kindwall-Keller TL, et al. Older patients with myeloma derive similar benefit from autologous transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 20: 1796-803. PMID 25046833 DOI: 10.1016/J.Bbmt.2014.07.013 |
0.389 |
|
| 2014 |
Wirk B, Fenske TS, Hamadani M, Zhang MJ, Hu ZH, Akpek G, Aljurf MD, Armand P, Ayala E, Bachanova V, Bolwell B, Cairo MS, Cashen A, Chen YB, Costa LJ, et al. Outcomes of hematopoietic cell transplantation for diffuse large B cell lymphoma transformed from follicular lymphoma. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 20: 951-9. PMID 24641828 DOI: 10.1016/j.bbmt.2014.03.014 |
0.361 |
|
| 2014 |
Weisdorf D, Eapen M, Ruggeri A, Zhang MJ, Zhong X, Brunstein C, Ustun C, Rocha V, Gluckman E. Alternative donor transplantation for older patients with acute myeloid leukemia in first complete remission: a center for international blood and marrow transplant research-eurocord analysis. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 20: 816-22. PMID 24582782 DOI: 10.1016/j.bbmt.2014.02.020 |
0.421 |
|
| 2014 |
Kuwatsuka Y, Atsuta Y, Horowitz MM, Inagaki J, Kanda J, Kato K, Koh K, Zhang MJ, Eapen M. Graft-versus-host disease and survival after cord blood transplantation for acute leukemia: a comparison of Japanese versus White populations. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 20: 662-7. PMID 24525277 DOI: 10.1016/j.bbmt.2014.01.020 |
0.414 |
|
| 2014 |
Bitan M, He W, Zhang MJ, Abdel-Azim H, Ayas MF, Bielorai B, Carpenter PA, Cairo MS, Diaz MA, Horan JT, Jodele S, Kitko CL, Schultz KR, Kletzel M, Kasow KA, et al. Transplantation for children with acute myeloid leukemia: a comparison of outcomes with reduced intensity and myeloablative regimens. Blood. 123: 1615-20. PMID 24435046 DOI: 10.1182/blood-2013-10-535716 |
0.405 |
|
| 2014 |
Hitzler JK, He W, Doyle J, Cairo M, Camitta BM, Chan KW, Diaz Perez MA, Fraser C, Gross TG, Horan JT, Kennedy-Nasser AA, Kitko C, Kurtzberg J, Lehmann L, O'Brien T, ... ... Zhang MJ, et al. Outcome of transplantation for acute lymphoblastic leukemia in children with Down syndrome. Pediatric Blood & Cancer. 61: 1126-8. PMID 24391118 DOI: 10.1002/pbc.24918 |
0.398 |
|
| 2014 |
Fenske TS, Zhang MJ, Carreras J, Ayala E, Burns LJ, Cashen A, Costa LJ, Freytes CO, Gale RP, Hamadani M, Holmberg LA, Inwards DJ, Lazarus HM, Maziarz RT, Munker R, et al. Autologous or reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chemotherapy-sensitive mantle-cell lymphoma: analysis of transplantation timing and modality. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 273-81. PMID 24344210 DOI: 10.1200/JCO.2013.49.2454 |
0.388 |
|
| 2014 |
Saad A, Mahindra A, Zhang MJ, Zhong X, Costa LJ, Dispenzieri A, Drobyski WR, Freytes CO, Gale RP, Gasparetto CJ, Holmberg LA, Kamble RT, Krishnan AY, Kyle RA, Marks D, et al. Hematopoietic cell transplant comorbidity index is predictive of survival after autologous hematopoietic cell transplantation in multiple myeloma. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 20: 402-408.e1. PMID 24342394 DOI: 10.1016/j.bbmt.2013.12.557 |
0.375 |
|
| 2014 |
Saber W, Steinert P, Zhang M, Chen M, Horowitz MM. Impact of palifermin use on pediatric patient (PedPts) hematopoietic cell transplant (HCT) outcomes. Journal of Clinical Oncology. 32: 7117-7117. DOI: 10.1200/Jco.2014.32.15_Suppl.7117 |
0.475 |
|
| 2014 |
Besien KV, Artz AS, Zhang M, Cushing M, Wickrema A, Korman S, Liu H, Gergis U, Stock W, Mayer SA, Bishop MR, Shore T, Larson RA, Hari P. Haplo+cord transplantation: Neutrophil and platelet recovery and long-term survival compared to double umbilical cord blood (UCB) transplantation--A case-cohort analysis. Journal of Clinical Oncology. 32: 7004-7004. DOI: 10.1200/Jco.2014.32.15_Suppl.7004 |
0.437 |
|
| 2014 |
Ciurea SO, Zhang M, Bacigalupo A, Bashey A, Appelbaum FR, Antin JH, Chen J, Devine SM, Fowler DH, Nakamura R, Perales M, Pingali SR, Porter DL, Ringdén O, Rocha V, et al. Survival after T-Cell Replete Haplo-Identical Related Donor Transplant Using Post-Transplant Cyclophosphamide Compared with Matched Unrelated Donor Transplant for Acute Myeloid Leukemia Blood. 124: 679-679. DOI: 10.1182/Blood.V124.21.679.679 |
0.512 |
|
| 2014 |
Seftel MD, Neuberg D, Zhang M, Wang H, Bergeron J, Couban S, DeAngelo DJ, Lima MJd, Devine SM, Eapen M, Horowitz MM, Pasquini MC, Rizzo JD, Saber W, Sallan SE, et al. Superiority of Pediatric Chemotherapy over Allogeneic Hematopoietic Cell Transplantation for Philadelphia Chromosome Negative Adult ALL in First Complete Remission: A Combined Analysis of Dana-Farber ALL Consortium and CIBMTR Cohorts Blood. 124: 319-319. DOI: 10.1182/Blood.V124.21.319.319 |
0.446 |
|
| 2014 |
Costa LJ, Uy GL, Hari PN, Zhang M, Huang J, Krishnan A, Mark TM, D'Souza A. Contribution of Chemotherapy Mobilization to Disease Control in Multiple Myeloma Treated with Autologous Transplantation Blood. 124: 2447-2447. DOI: 10.1182/Blood.V124.21.2447.2447 |
0.508 |
|
| 2014 |
D'Souza A, Wirk B, Zhang M, Huang J, Krishnan A, Mark TM, Gasparetto CJ, Hari PN. Improved Outcomes of Autologous Hematopoietic Cell Transplantation (AHCT) for Light Chain (AL) Amyloidosis: A Center for International Blood and Marrow Transplant Registry (CIBMTR) Study Blood. 124: 193-193. DOI: 10.1182/Blood.V124.21.193.193 |
0.493 |
|
| 2014 |
Mehta PA, Eapen M, Zhang M, He W, Seber A, Kitko CL, Hale GA, Davies SM. Transplant Outcomes for Children with Hypodiploid Acute Lymphoblastic Leukemia: The Cibmtr Experience Biology of Blood and Marrow Transplantation. 20. DOI: 10.1016/J.Bbmt.2013.12.110 |
0.5 |
|
| 2014 |
Holter-Chakrabarty JL, Zhang M, Zhu X, Akpek G, Aljurf MD, Artz AS, Baron F, Borden AM, Bredeson CN, Dvorak CC, Epstein RB, Lazarus HM, Olsson R, Pierson N, Selby GB, et al. Sequence of Cyclophosphamide (Cy) and Total Body Irradiation (TBI) Prior to Hematopoietic Cell Transplant (HCT) for Patients with Acute Leukemia: Impact upon Complications and Patient Outcome Biology of Blood and Marrow Transplantation. 20. DOI: 10.1016/J.Bbmt.2013.12.017 |
0.354 |
|
| 2013 |
Hahn T, McCarthy PL, Carreras J, Zhang MJ, Lazarus HM, Laport GG, Montoto S, Hari PN. Simplified validated prognostic model for progression-free survival after autologous transplantation for hodgkin lymphoma. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 19: 1740-4. PMID 24096096 DOI: 10.1016/j.bbmt.2013.09.018 |
0.396 |
|
| 2013 |
Costa LJ, Zhang MJ, Zhong X, Dispenzieri A, Lonial S, Krishnan A, Freytes C, Vesole D, Gale RP, Anderson K, Wirk B, Savani BN, Waller EK, Schouten H, Lazarus H, et al. Trends in utilization and outcomes of autologous transplantation as early therapy for multiple myeloma. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 19: 1615-24. PMID 23939198 DOI: 10.1016/j.bbmt.2013.08.002 |
0.379 |
|
| 2013 |
Saber W, Cutler CS, Nakamura R, Zhang MJ, Atallah E, Rizzo JD, Maziarz RT, Cortes J, Kalaycio ME, Horowitz MM. Impact of donor source on hematopoietic cell transplantation outcomes for patients with myelodysplastic syndromes (MDS). Blood. 122: 1974-82. PMID 23847196 DOI: 10.1182/blood-2013-04-496778 |
0.421 |
|
| 2013 |
Maziarz RT, Wang Z, Zhang MJ, Bolwell BJ, Chen AI, Fenske TS, Freytes CO, Gale RP, Gibson J, Hayes-Lattin BM, Holmberg L, Inwards DJ, Isola LM, Khoury HJ, Lewis VA, et al. Autologous haematopoietic cell transplantation for non-Hodgkin lymphoma with secondary CNS involvement. British Journal of Haematology. 162: 648-56. PMID 23829536 DOI: 10.1111/bjh.12451 |
0.358 |
|
| 2013 |
Mao Y, Xu F, Zhang MJ, Liu JL, Yang J, Wang MJ, Zhang SF, Zhang YL, Yan JQ. Equity of health service utilization of urban residents: data from a western Chinese city. Chinese Medical Journal. 126: 2510-6. PMID 23823826 |
0.349 |
|
| 2013 |
Cornell RF, Hari P, Zhang MJ, Zhong X, Thompson J, Fenske TS, Horowitz MM, Komorowski R, Palmer J, Pasquini MC, Rizzo JD, Saber W, Thomas M, Drobyski WR. Divergent effects of novel immunomodulatory agents and cyclophosphamide on the risk of engraftment syndrome after autologous peripheral blood stem cell transplantation for multiple myeloma. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 19: 1368-73. PMID 23806770 DOI: 10.1016/j.bbmt.2013.06.017 |
0.358 |
|
| 2013 |
Hitzler JK, He W, Doyle J, Cairo M, Camitta BM, Chan KW, Diaz Perez MA, Fraser C, Gross TG, Horan JT, Kennedy-Nasser AA, Kitko C, Kurtzberg J, Lehmann L, O'Brien T, ... ... Zhang MJ, et al. Outcome of transplantation for acute myelogenous leukemia in children with Down syndrome. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 19: 893-7. PMID 23467128 DOI: 10.1016/j.bbmt.2013.02.017 |
0.412 |
|
| 2013 |
Zhao L, Liu JM, He XY, Zhao HY, Sun LH, Tao B, Zhang MJ, Chen X, Wang WQ, Ning G. The changing clinical patterns of primary hyperparathyroidism in Chinese patients: data from 2000 to 2010 in a single clinical center. The Journal of Clinical Endocrinology and Metabolism. 98: 721-8. PMID 23365127 DOI: 10.1210/jc.2012-2914 |
0.376 |
|
| 2013 |
Tracey J, Zhang MJ, Thiel E, Sobocinski KA, Eapen M. Transplantation conditioning regimens and outcomes after allogeneic hematopoietic cell transplantation in children and adolescents with acute lymphoblastic leukemia. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 19: 255-9. PMID 23041605 DOI: 10.1016/J.Bbmt.2012.09.019 |
0.5 |
|
| 2013 |
Scheike TH, Maiers MJ, Rocha V, Zhang MJ. Competing risks with missing covariates: effect of haplotypematch on hematopoietic cell transplant patients. Lifetime Data Analysis. 19: 19-32. PMID 22968448 DOI: 10.1007/S10985-012-9229-1 |
0.439 |
|
| 2013 |
Logan BR, Zhang MJ. The use of group sequential designs with common competing risks tests. Statistics in Medicine. 32: 899-913. PMID 22945865 DOI: 10.1002/Sim.5597 |
0.346 |
|
| 2013 |
Deng YH, Zhao L, Zhang MJ, Pan CM, Zhao SX, Zhao HY, Sun LH, Tao B, Song HD, Wang WQ, Ning G, Liu JM. The influence of the genetic and non-genetic factors on bone mineral density and osteoporotic fractures in Chinese women. Endocrine. 43: 127-35. PMID 22798246 DOI: 10.1007/s12020-012-9726-8 |
0.374 |
|
| 2013 |
Sharma M, Zhang M, Zhong X, Gasparetto CJ, Krishnan AY, Lonial S, Hari P. Multiple Myeloma (MM) In Older (>70 year) Patients - Similar Benefit From Autologous Hematopoietic Cell Transplantation (AHCT) Compared With Younger Patients Blood. 122: 416-416. DOI: 10.1182/Blood.V122.21.416.416 |
0.46 |
|
| 2013 |
Eapen M, Ruggeri A, Zhang M, Zhong X, Brunstein C, Ustun C, Rocha V, Gluckman E. Alternative Donor Hematopoietic Transplantation For Patients Older Than 50 Years With AML In First Complete Remission: Unrelated Donor and Umbilical Cord Blood Transplantation Outcomes Blood. 122: 302-302. DOI: 10.1182/Blood.V122.21.302.302 |
0.548 |
|
| 2013 |
Pavletic SZ, Flowers MED, Zhang M, Carreras J, Smith SM, Maloney DG, Montoto S, Cutler CS, Spellman SR, Arora M, Saber W. Association Of Graft Vs. Host Disease (GVHD) With a Lower Relapse/Progression Rate After Allogeneic Hemopoietic Stem Cell Transplantation (HSCT) With Reduced Intentsity Conditioning In Patients With Follicular and Mantle Cell Lymphoma: A Cibmtr Analysis Blood. 122: 2093-2093. DOI: 10.1182/Blood.V122.21.2093.2093 |
0.5 |
|
| 2013 |
Bejanyan N, Weisdorf DJ, Wang H, Logan BR, Devine SM, de Lima M, Bunjes DW, Zhang M. Survival Of AML Patients Relapsing After Allogeneic Stem Cell Transplantation: A Center For International Blood and Marrow Transplant Research Study Blood. 122: 2072-2072. DOI: 10.1182/Blood.V122.21.2072.2072 |
0.498 |
|
| 2013 |
DiPrima S, Gragert L, Albrecht M, Zhang M, Zhong X, Hari P, Beksac M, Maiers M. 134-P: Extension Of Relative Predispositional Effects (Rpe) Method To Handle Multiple Imputation And Multivariate Regression Human Immunology. 74: 142. DOI: 10.1016/J.Humimm.2013.08.209 |
0.327 |
|
| 2013 |
Bachanova V, Marks D, Zhang M, Wang H, Weisdorf DJ. Allogeneic Transplantation for Ph+ Acute Lymphoblastic Leukemia (ALL): Impact of Conditioning Intensity, Tyrosine Kinase Inhibitors (TKI) and Minimal Residual Disease (MRD) Biology of Blood and Marrow Transplantation. 19. DOI: 10.1016/J.Bbmt.2012.11.267 |
0.358 |
|
| 2013 |
Cornell RF, Drobyski W, Zhong X, Thompson J, Horowitz MM, Fenske T, Palmer J, Pasquini MC, Saber W, Thomas M, Randhawa JK, Zhang M, Hari PN. Risk Factors and Clinical Features of Engraftment Syndrome After Autologous Hematopoietic Cell Transplantation (AHCT) Biology of Blood and Marrow Transplantation. 19. DOI: 10.1016/J.Bbmt.2012.11.064 |
0.407 |
|
| 2012 |
Rocha V, Spellman S, Zhang MJ, Ruggeri A, Purtill D, Brady C, Baxter-Lowe LA, Baudoux E, Bergamaschi P, Chow R, Freed B, Koegler G, Kurtzberg J, Larghero J, Lecchi L, et al. Effect of HLA-matching recipients to donor noninherited maternal antigens on outcomes after mismatched umbilical cord blood transplantation for hematologic malignancy. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 18: 1890-6. PMID 22814031 DOI: 10.1016/j.bbmt.2012.07.010 |
0.414 |
|
| 2012 |
Weisdorf D, Zhang MJ, Arora M, Horowitz MM, Rizzo JD, Eapen M. Graft-versus-host disease induced graft-versus-leukemia effect: greater impact on relapse and disease-free survival after reduced intensity conditioning. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 18: 1727-33. PMID 22766220 DOI: 10.1016/j.bbmt.2012.06.014 |
0.372 |
|
| 2012 |
Zhang MJ, Davies SM, Camitta BM, Logan B, Tiedemann K, Eapen M, Thiel EL. Comparison of outcomes after HLA-matched sibling and unrelated donor transplantation for children with high-risk acute lymphoblastic leukemia. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 18: 1204-10. PMID 22406037 DOI: 10.1016/J.Bbmt.2012.01.007 |
0.508 |
|
| 2012 |
Saber W, Opie S, Rizzo JD, Zhang MJ, Horowitz MM, Schriber J. Outcomes after matched unrelated donor versus identical sibling hematopoietic cell transplantation in adults with acute myelogenous leukemia. Blood. 119: 3908-16. PMID 22327226 DOI: 10.1182/Blood-2011-09-381699 |
0.529 |
|
| 2012 |
Freytes CO, Zhang MJ, Carreras J, Burns LJ, Gale RP, Isola L, Perales MA, Seftel M, Vose JM, Miller AM, Gibson J, Gross TG, Rowlings PA, Inwards DJ, Pavlovsky S, et al. Outcome of lower-intensity allogeneic transplantation in non-Hodgkin lymphoma after autologous transplantation failure. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 18: 1255-64. PMID 22198543 DOI: 10.1016/J.Bbmt.2011.12.581 |
0.529 |
|
| 2012 |
Xiao SM, Kung AW, Gao Y, Lau KS, Ma A, Zhang ZL, Liu JM, Xia W, He JW, Zhao L, Nie M, Fu WZ, Zhang MJ, Sun J, Kwan JS, et al. Post-genome wide association studies and functional analyses identify association of MPP7 gene variants with site-specific bone mineral density. Human Molecular Genetics. 21: 1648-57. PMID 22171069 DOI: 10.1093/hmg/ddr586 |
0.391 |
|
| 2012 |
Mahindra A, Kalaycio ME, Vela-Ojeda J, Vesole DH, Zhang MJ, Li P, Berenson JR, Bird JM, Dispenzieri A, Gajewski JL, Gale RP, Holmberg L, Kumar S, Kyle RA, Lazarus HM, et al. Hematopoietic cell transplantation for primary plasma cell leukemia: results from the Center for International Blood and Marrow Transplant Research. Leukemia. 26: 1091-7. PMID 22042147 DOI: 10.1038/Leu.2011.312 |
0.463 |
|
| 2012 |
Jagasia M, Arora M, Flowers ME, Chao NJ, McCarthy PL, Cutler CS, Urbano-Ispizua A, Pavletic SZ, Haagenson MD, Zhang MJ, Antin JH, Bolwell BJ, Bredeson C, Cahn JY, Cairo M, et al. Risk factors for acute GVHD and survival after hematopoietic cell transplantation. Blood. 119: 296-307. PMID 22010102 DOI: 10.1182/blood-2011-06-364265 |
0.43 |
|
| 2012 |
Armand P, Kim HT, Zhang MJ, Perez WS, Dal Cin PS, Klumpp TR, Waller EK, Litzow MR, Liesveld JL, Lazarus HM, Artz AS, Gupta V, Savani BN, McCarthy PL, Cahn JY, et al. Classifying cytogenetics in patients with acute myelogenous leukemia in complete remission undergoing allogeneic transplantation: a Center for International Blood and Marrow Transplant Research study. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 18: 280-8. PMID 21810400 DOI: 10.1016/J.Bbmt.2011.07.024 |
0.503 |
|
| 2012 |
Luger SM, Ringdén O, Zhang MJ, Pérez WS, Bishop MR, Bornhauser M, Bredeson CN, Cairo MS, Copelan EA, Gale RP, Giralt SA, Gulbas Z, Gupta V, Hale GA, Lazarus HM, et al. Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDS. Bone Marrow Transplantation. 47: 203-11. PMID 21441963 DOI: 10.1038/Bmt.2011.69 |
0.518 |
|
| 2012 |
Vij R, Zhong X, Zhang M, Lonial S, Dispenzieri A, Hari P. Pre-Transplant Salvage Therapy Prior to Autologous Transplant (AHCT) in Patients Not Responding to Initial Induction for Multiple Myeloma (MM) Blood. 120: 597-597. DOI: 10.1182/Blood.V120.21.597.597 |
0.49 |
|
| 2012 |
Costa LJ, Zhong X, Zhang M, Lonial S, Krishnan A, Dispenzieri A, Hari P. Trends in Utilization and Outcomes of Autologous Hematopoietic Cell Transplantation (AHCT) in the Upfront Management of Patients with Multiple Myeloma: A Cibmtr Analysis Blood. 120: 596-596. DOI: 10.1182/Blood.V120.21.596.596 |
0.491 |
|
| 2012 |
Schmidt SL, Blust L, Knudson P, Richter E, Fenske TS, Palmer J, Zhang M, Eastwood D, Atallah E. The Effect of Hyperglycemia On the Outcome of Patients with Acute Myelogenous Leukemia Blood. 120: 4323-4323. DOI: 10.1182/Blood.V120.21.4323.4323 |
0.375 |
|
| 2012 |
Mahindra A, Saad AA, Zhang M, Zhong X, Dispenzieri A, Krishnan A, Lonial S, Pasquini MC, Hari P. Hematopoietic Cell Transplant Co-Morbidity Index (HCTCI) and Multiple Myeloma (MM) Survival After Autologous Hematopoietic Cell Transplantation (AHCT) Blood. 120: 4217-4217. DOI: 10.1182/Blood.V120.21.4217.4217 |
0.511 |
|
| 2012 |
Saber W, Cutler C, Nakamura R, Zhang M, Atallah E, Rizzo JD, Maziarz RT, Cortes JE, Kalaycio M, Horowitz MM. Comparison of Outcomes After Related and Unrelated Hematopoietic Cell Transplantation in Adults with Myelodysplastic Syndromes: A Report From the Center for International Blood and Marrow Transplant Research (CIBMTR) Blood. 120: 355-355. DOI: 10.1182/Blood.V120.21.355.355 |
0.506 |
|
| 2012 |
Hitzler JK, He W, Doyle JJ, Bitan M, Cairo MS, Camitta B, Chan KW, Diaz MA, Fraser C, Gross T, Horan JT, Kasow KA, Kennedy-Nasser A, Kitko C, Kurtzberg J, ... ... Zhang M, et al. Outcome of Transplantation for Acute Leukemia in Down Syndrome Blood. 120: 1991-1991. DOI: 10.1182/Blood.V120.21.1991.1991 |
0.491 |
|
| 2011 |
Scheike TH, Zhang MJ. Analyzing Competing Risk Data Using the R timereg Package. Journal of Statistical Software. 38. PMID 22707920 DOI: 10.18637/Jss.V038.I02 |
0.311 |
|
| 2011 |
Scheike TH, Martinussen T, Zhang MJ. The additive risk model for estimation of effect of haplotype match in BMT studies. Scandinavian Journal of Statistics, Theory and Applications. 38: 409-423. PMID 21927531 DOI: 10.1111/J.1467-9469.2010.00720.X |
0.379 |
|
| 2011 |
Passweg JR, Zhang MJ, Rocha V, Kan F, Champlin RE, Isola LM, Gee AP, Gibson J, Laughlin MJ, Lazarus HM, Loren A, Marks DI, Gratwohl A, Eapen M. Donor characteristics affecting graft failure, graft-versus-host disease, and survival after unrelated donor transplantation with reduced-intensity conditioning for hematologic malignancies. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 17: 1869-73. PMID 21771571 DOI: 10.1016/j.bbmt.2011.07.008 |
0.399 |
|
| 2011 |
Farag SS, Maharry K, Zhang MJ, Pérez WS, George SL, Mrózek K, DiPersio J, Bunjes DW, Marcucci G, Baer MR, Cairo M, Copelan E, Cutler CS, Isola L, Lazarus HM, et al. Comparison of reduced-intensity hematopoietic cell transplantation with chemotherapy in patients age 60-70 years with acute myelogenous leukemia in first remission. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 17: 1796-803. PMID 21699879 DOI: 10.1016/j.bbmt.2011.06.005 |
0.406 |
|
| 2011 |
Kumar S, Zhang MJ, Li P, Dispenzieri A, Milone GA, Lonial S, Krishnan A, Maiolino A, Wirk B, Weiss B, Freytes CO, Vogl DT, Vesole DH, Lazarus HM, Meehan KR, et al. Trends in allogeneic stem cell transplantation for multiple myeloma: a CIBMTR analysis. Blood. 118: 1979-88. PMID 21690560 DOI: 10.1182/blood-2011-02-337329 |
0.429 |
|
| 2011 |
Zhao L, Cui B, Liu JM, Zhang MJ, Zhao HY, Sun LH, Tao B, Zhang LZ, Ning G. Interactions of osteoporosis candidate genes for age at menarche, age at natural menopause, and maximal height in Han Chinese women. Menopause (New York, N.Y.). 18: 1018-25. PMID 21646926 DOI: 10.1097/gme.0b013e318213545a |
0.341 |
|
| 2011 |
Zhao L, Zhang MJ, Zhao HY, Sun LH, Li JL, Tao B, Wang WQ, Ning G, Liu JM. PTH inhibition rate is useful in the detection of early-stage primary hyperparathyroidism. Clinical Biochemistry. 44: 844-8. PMID 21524645 DOI: 10.1016/j.clinbiochem.2011.03.142 |
0.34 |
|
| 2011 |
Gu LQ, Zhao L, Zhu W, Li FY, Zhang MJ, Liu Y, Liu JM, Ning G, Zhao YJ. Relationships between serum levels of thyroid hormones and serum concentrations of asymmetric dimethylarginine (ADMA) and N-terminal-pro-B-type natriuretic peptide (NT-proBNP) in patients with Graves' disease. Endocrine. 39: 266-71. PMID 21387129 DOI: 10.1007/s12020-011-9436-7 |
0.36 |
|
| 2011 |
Dong L, Wu T, Gao ZY, Zhang MJ, Kan F, Spellman SR, Tan XY, Zhao YL, Wang JB, Lu DP, Miklos D, Petersdorf E, Fernandez-Vina M, Lee SJ. The outcomes of family haploidentical hematopoietic stem cell transplantation in hematologic malignancies are not associated with patient age. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 17: 1205-13. PMID 21193055 DOI: 10.1016/j.bbmt.2010.12.703 |
0.372 |
|
| 2011 |
Woodard P, Carpenter PA, Davies SM, Gross TG, He W, Zhang MJ, Horn BN, Margolis DA, Perentesis JP, Sanders JE, Schultz KR, Seber A, Woods WG, Eapen M. Unrelated donor bone marrow transplantation for myelodysplastic syndrome in children. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 17: 723-8. PMID 20813197 DOI: 10.1016/j.bbmt.2010.08.016 |
0.397 |
|
| 2011 |
Zhang X, Zhang MJ. SAS macros for estimation of direct adjusted cumulative incidence curves under proportional subdistribution hazards models. Computer Methods and Programs in Biomedicine. 101: 87-93. PMID 20724020 DOI: 10.1016/J.Cmpb.2010.07.005 |
0.336 |
|
| 2011 |
Hahn T, McCarthy PL, Carreras J, Zhang M, Lazarus HM, Laport GG, Montoto S, Maloney DG, Hari P. A CIBMTR Prognostic Model for Progression-Free Survival (PFS) After Autologous Hematopoietic Cell Transplantation (AHCT) for Relapsed or Refractory Hodgkin Lymphoma (HL) Blood. 118: 499-499. DOI: 10.1182/Blood.V118.21.499.499 |
0.467 |
|
| 2011 |
Weisdorf DJ, Zhang M, Arora M, Rizzo JD, Horowitz MM, Eapen M. Graft-Versus-Host Disease (GVHD) Induced Graft-Versus-Leukemia (GVL) Effect: More Impact on Later Relapse and Disease-Free Survival Following Reduced Intensity Conditioning Blood. 118: 1014-1014. DOI: 10.1182/Blood.V118.21.1014.1014 |
0.484 |
|
| 2010 |
Reece DE, Vesole DH, Shrestha S, Zhang MJ, Pérez WS, Dispenzieri A, Milone GA, Abidi M, Atkins H, Bashey A, Bredeson CN, Boza WB, Freytes CO, Gale RP, Gajewski JL, et al. Outcome of patients with IgD and IgM multiple myeloma undergoing autologous hematopoietic stem cell transplantation: a retrospective CIBMTR study. Clinical Lymphoma, Myeloma & Leukemia. 10: 458-63. PMID 21156462 DOI: 10.1182/Blood.V112.11.3328.3328 |
0.436 |
|
| 2010 |
Joshua TV, Rizzo JD, Zhang MJ, Hari PN, Kurian S, Pasquini M, Majhail NS, Lee SJ, Horowitz MM. Access to hematopoietic stem cell transplantation: effect of race and sex. Cancer. 116: 3469-76. PMID 20564154 DOI: 10.1002/cncr.25297 |
0.318 |
|
| 2010 |
Eapen M, Rocha V, Sanz G, Scaradavou A, Zhang MJ, Arcese W, Sirvent A, Champlin RE, Chao N, Gee AP, Isola L, Laughlin MJ, Marks DI, Nabhan S, Ruggeri A, et al. Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis. The Lancet. Oncology. 11: 653-60. PMID 20558104 DOI: 10.1016/S1470-2045(10)70127-3 |
0.493 |
|
| 2010 |
Liu JM, Zhang MJ, Zhao L, Cui B, Li ZB, Zhao HY, Sun LH, Tao B, Li M, Ning G. Analysis of recently identified osteoporosis susceptibility genes in Han Chinese women. The Journal of Clinical Endocrinology and Metabolism. 95: E112-20. PMID 20554715 DOI: 10.1210/jc.2009-2768 |
0.333 |
|
| 2010 |
Pavletic SZ, Kumar S, Mohty M, de Lima M, Foran JM, Pasquini M, Zhang MJ, Giralt S, Bishop MR, Weisdorf D. NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on the Epidemiology and Natural History of Relapse following Allogeneic Cell Transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 16: 871-90. PMID 20399876 DOI: 10.1016/j.bbmt.2010.04.004 |
0.384 |
|
| 2010 |
Kung AW, Xiao SM, Cherny S, Li GH, Gao Y, Tso G, Lau KS, Luk KD, Liu JM, Cui B, Zhang MJ, Zhang ZL, He JW, Yue H, Xia WB, et al. Association of JAG1 with bone mineral density and osteoporotic fractures: a genome-wide association study and follow-up replication studies. American Journal of Human Genetics. 86: 229-39. PMID 20096396 DOI: 10.1016/J.Ajhg.2009.12.014 |
0.387 |
|
| 2010 |
Lazarus HM, Zhang MJ, Carreras J, Hayes-Lattin BM, Ataergin AS, Bitran JD, Bolwell BJ, Freytes CO, Gale RP, Goldstein SC, Hale GA, Inwards DJ, Klumpp TR, Marks DI, Maziarz RT, et al. A comparison of HLA-identical sibling allogeneic versus autologous transplantation for diffuse large B cell lymphoma: a report from the CIBMTR. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 16: 35-45. PMID 20053330 DOI: 10.1016/j.bbmt.2009.08.011 |
0.426 |
|
| 2010 |
Hari PN, Majhail NS, Zhang MJ, Hassebroek A, Siddiqui F, Ballen K, Bashey A, Bird J, Freytes CO, Gibson J, Hale G, Holmberg L, Kamble R, Kyle RA, Lazarus HM, et al. Race and outcomes of autologous hematopoietic cell transplantation for multiple myeloma. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 16: 395-402. PMID 19922808 DOI: 10.1016/j.bbmt.2009.11.007 |
0.375 |
|
| 2010 |
Ballen KK, Shrestha S, Sobocinski KA, Zhang MJ, Bashey A, Bolwell BJ, Cervantes F, Devine SM, Gale RP, Gupta V, Hahn TE, Hogan WJ, Kröger N, Litzow MR, Marks DI, et al. Outcome of transplantation for myelofibrosis. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 16: 358-67. PMID 19879949 DOI: 10.1016/j.bbmt.2009.10.025 |
0.424 |
|
| 2010 |
Gross TG, Hale GA, He W, Camitta BM, Sanders JE, Cairo MS, Hayashi RJ, Termuhlen AM, Zhang MJ, Davies SM, Eapen M. Hematopoietic stem cell transplantation for refractory or recurrent non-Hodgkin lymphoma in children and adolescents. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 16: 223-30. PMID 19800015 DOI: 10.1016/j.bbmt.2009.09.021 |
0.395 |
|
| 2010 |
Gu LQ, Zhu W, Pan CM, Zhao L, Zhang MJ, Liu JM, Song HD, Ning G, Zhao YJ. Tumor necrosis factor alpha (TNF-alpha) polymorphisms in Chinese patients with Graves' disease. Clinical Biochemistry. 43: 223-7. PMID 19732761 DOI: 10.1016/j.clinbiochem.2009.08.012 |
0.352 |
|
| 2010 |
Jagasia M, Arora M, Flowers M, Chao NJ, McCarthy PL, Antin JH, Bolwell BJ, Bredeson C, Cahn J, Cairo MS, Cutler C, Gale RP, Gupta V, Haagenson MD, Horowitz MM, ... ... Zhang M, et al. Risk-Factors for Acute Graft-Versus-Host Disease and Survival After Hematopoietic Cell Transplantation From Siblings and Unrelated Donors – An Analysis of the CIBMTR Blood. 116: 897-897. DOI: 10.1182/Blood.V116.21.897.897 |
0.482 |
|
| 2010 |
Armand P, Perez W, Zhang M, Kim H, Klumpp TR, Cin PD, Waller EK, Litzow MR, Liesveld JL, Lazarus HM, Artz A, Gupta V, Savani BN, McCarthy PL, Cahn J, et al. Cytogenetics Abnormalities Predict the Outcome of Allogeneic Transplantation In AML: A CIBMTR Study Blood. 116: 680-680. DOI: 10.1182/Blood.V116.21.680.680 |
0.453 |
|
| 2010 |
Maziarz RT, Zhang M, Wang Z, Laport GG, Lazarus HM, Montoto S, Hari P. CNS Remission at the Time of Autologous Stem Cell Transplantation Improves Outcome for Patients with Non-Hodgkin's Lymphoma with Pre-Existing CNS Involvement: a CIBMTR Analysis Blood. 116: 371-371. DOI: 10.1182/Blood.V116.21.371.371 |
0.449 |
|
| 2010 |
Tracey J, Zhang M, Sobocinski KA, Thiel EL, Eckrich MJ, Pasquini MC, Saber W, Weisdorf DJ, Horowitz MM, Eapen M. Transplant Conditioning Regimens and Outcomes After Allogeneic Hematopoietic Cell Transplantation (HCT) In Children and Adolescents with Acute Lymphoblastic Leukemia (ALL) Blood. 116: 3506-3506. DOI: 10.1182/Blood.V116.21.3506.3506 |
0.474 |
|
| 2009 |
Fenske TS, Hari PN, Carreras J, Zhang MJ, Kamble RT, Bolwell BJ, Cairo MS, Champlin RE, Chen YB, Freytes CO, Gale RP, Hale GA, Ilhan O, Khoury HJ, Lister J, et al. Impact of pre-transplant rituximab on survival after autologous hematopoietic stem cell transplantation for diffuse large B cell lymphoma. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 15: 1455-64. PMID 19822306 DOI: 10.1016/j.bbmt.2009.07.017 |
0.398 |
|
| 2009 |
Majhail NS, Bajorunaite R, Lazarus HM, Wang Z, Klein JP, Zhang MJ, Rizzo JD. Long-term survival and late relapse in 2-year survivors of autologous haematopoietic cell transplantation for Hodgkin and non-Hodgkin lymphoma. British Journal of Haematology. 147: 129-39. PMID 19573079 DOI: 10.1111/J.1365-2141.2009.07798.X |
0.369 |
|
| 2009 |
Hari PN, Zhang MJ, Roy V, Pérez WS, Bashey A, To LB, Elfenbein G, Freytes CO, Gale RP, Gibson J, Kyle RA, Lazarus HM, McCarthy PL, Milone GA, Pavlovsky S, et al. Is the International Staging System superior to the Durie-Salmon staging system? A comparison in multiple myeloma patients undergoing autologous transplant. Leukemia. 23: 1528-34. PMID 19322205 DOI: 10.1038/Leu.2009.61 |
0.368 |
|
| 2009 |
Pasquini MC, Zhang M, Hari PN, Montoto S, Laport GG, Lazarus HM, Attal M, Russell NH, Thomson K, Vernant J, Canals C, Schouten H, Sureda A. Comparison of Unrelated and Sibling Donor Allogeneic Hematopoietic Cell Transplantation (HCT) for Follicular Lymphoma (FL) - From the Lymphoma Working Party, European Group for Blood and Marrow Transplantation (EBMT) and Center for International Blood and Marrow Transplant Research (CIBMTR). Blood. 114: 874-874. DOI: 10.1182/Blood.V114.22.874.874 |
0.532 |
|
| 2009 |
Farag S, Maharry K, Perez WS, Zhang M, DiPersio JF, Bunjes D, Marcucci G, Baer MR, Larson RA, Tallman M, Bloomfield CD, Weisdorf DJ. Allogeneic Hematopoietic Stem Cell Transplantation (HCT) Compared to Chemotherapy Only in Acute Myeloid Leukemia (AML) Patients 60 Years and Older: A Center for International Blood and Marrow Transplantation Research (CIBMTR)/ Cancer and Leukemia Group B (CALGB) Study. Blood. 114: 657-657. DOI: 10.1182/Blood.V114.22.657.657 |
0.49 |
|
| 2009 |
Kumar S, Shrestha S, Zhang M, Dispenzieri A, Milone GA, Lonial S, Hari PN. Allogeneic Stem Cell Transplantation (SCT) for Multiple Myeloma (MM) - What Has Changed? : A CIBMTR Analysis From 1989 – 2005. Blood. 114: 54-54. DOI: 10.1182/Blood.V114.22.54.54 |
0.451 |
|
| 2009 |
Mahindra A, Vesole D, Kalaycio ME, Vela-Ojeda J, Shrestha S, Zhang M, Dispenzieri A, Milone GA, Lonial S, Hari PN. Autologous Hematopoietic Stem Cell Transplantation (HCT) is a Safe and Effective Treatment for Primary Plasma Cell Leukemia: The CIBMTR Experience. Blood. 114: 532-532. DOI: 10.1182/Blood.V114.22.532.532 |
0.502 |
|
| 2009 |
Hari PN, Barrett AJ, Shrestha S, Silva GTd, Zhang M, Dispenzieri A, Milone GA, Lonial S, Ringden O. Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplant (HSCT) for Myeloma (MM) - Chronic Graft Versus Host Disease (GVHD) is Associated with Lower Risk of Relapse and Superior Progression Free Survival (PFS) - A CIBMTR Analysis. Blood. 114: 53-53. DOI: 10.1182/Blood.V114.22.53.53 |
0.517 |
|
| 2009 |
Hahn T, McCarthy PL, Carreras J, Zhang M, Lazarus HM, Laport GG, Montoto S, Hari PN. Comparison of Prognostic Models for Autologous Hematopoietic Stem Cell Transplantation (AHCT) for Relapsed Hodgkin Lymphoma. Blood. 114: 1215-1215. DOI: 10.1182/Blood.V114.22.1215.1215 |
0.389 |
|
| 2008 |
Zhang MJ, Zhang X, Scheike TH. Modeling cumulative incidence function for competing risks data. Expert Review of Clinical Pharmacology. 1: 391-400. PMID 19829754 DOI: 10.1586/17512433.1.3.391 |
0.349 |
|
| 2008 |
Hahn T, McCarthy PL, Zhang MJ, Wang D, Arora M, Frangoul H, Gale RP, Hale GA, Horan J, Isola L, Maziarz RT, van Rood JJ, Gupta V, Halter J, Reddy V, et al. Risk factors for acute graft-versus-host disease after human leukocyte antigen-identical sibling transplants for adults with leukemia. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 5728-34. PMID 18981462 DOI: 10.1200/Jco.2008.17.6545 |
0.334 |
|
| 2008 |
Klein JP, Zhang MJ. Guest editor introduction to issue on transplant statistics. Lifetime Data Analysis. 14: 377-8. PMID 18949557 DOI: 10.1007/S10985-008-9103-3 |
0.494 |
|
| 2008 |
Pasquini R, Carreras J, Pasquini MC, Camitta BM, Fasth AL, Hale GA, Harris RE, Marsh JC, Robinson AJ, Zhang MJ, Eapen M, Wagner JE. HLA-matched sibling hematopoietic stem cell transplantation for fanconi anemia: comparison of irradiation and nonirradiation containing conditioning regimens. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 14: 1141-7. PMID 18804044 DOI: 10.1016/j.bbmt.2008.06.020 |
0.402 |
|
| 2008 |
Kumar S, Pérez WS, Zhang MJ, Ballen K, Bashey A, To LB, Bredeson CN, Cairo MS, Elfenbein GJ, Freytes CO, Gale RP, Gibson J, Kyle RA, Lacy MQ, Lazarus HM, et al. Comparable outcomes in nonsecretory and secretory multiple myeloma after autologous stem cell transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 14: 1134-40. PMID 18804043 DOI: 10.1016/j.bbmt.2008.07.011 |
0.437 |
|
| 2008 |
Bashey A, Pérez WS, Zhang MJ, Anderson KC, Ballen K, Berenson JR, To LB, Fonseca R, Freytes CO, Gale RP, Gibson J, Giralt SA, Kyle RA, Lazarus HM, Maharaj D, et al. Comparison of twin and autologous transplants for multiple myeloma. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 14: 1118-24. PMID 18804041 DOI: 10.1016/j.bbmt.2008.07.007 |
0.43 |
|
| 2008 |
Scheike TH, Zhang MJ. Flexible competing risks regression modeling and goodness-of-fit. Lifetime Data Analysis. 14: 464-83. PMID 18752067 DOI: 10.1007/S10985-008-9094-0 |
0.374 |
|
| 2008 |
Bredeson CN, Zhang MJ, Agovi MA, Bacigalupo A, Bahlis NJ, Ballen K, Brown C, Chaudhry MA, Horowitz MM, Kurian S, Quinlan D, Muehlenbien CE, Russell JA, Savoie L, Rizzo JD, et al. Outcomes following HSCT using fludarabine, busulfan, and thymoglobulin: a matched comparison to allogeneic transplants conditioned with busulfan and cyclophosphamide. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 14: 993-1003. PMID 18721762 DOI: 10.1016/J.Bbmt.2008.06.009 |
0.519 |
|
| 2008 |
Marks DI, Pérez WS, He W, Zhang MJ, Bishop MR, Bolwell BJ, Bredeson CN, Copelan EA, Gale RP, Gupta V, Hale GA, Isola LM, Jakubowski AA, Keating A, Klumpp TR, et al. Unrelated donor transplants in adults with Philadelphia-negative acute lymphoblastic leukemia in first complete remission. Blood. 112: 426-34. PMID 18398065 DOI: 10.1182/Blood-2007-12-128918 |
0.405 |
|
| 2008 |
Hari P, Carreras J, Zhang MJ, Gale RP, Bolwell BJ, Bredeson CN, Burns LJ, Cairo MS, Freytes CO, Goldstein SC, Hale GA, Inwards DJ, Lemaistre CF, Maharaj D, Marks DI, et al. Allogeneic transplants in follicular lymphoma: higher risk of disease progression after reduced-intensity compared to myeloablative conditioning. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 14: 236-45. PMID 18215784 DOI: 10.1016/j.bbmt.2007.11.004 |
0.437 |
|
| 2008 |
Schlenk RF, Pasquini MC, Pérez WS, Zhang MJ, Krauter J, Antin JH, Bashey A, Bolwell BJ, Büchner T, Cahn JY, Cairo MS, Copelan EA, Cutler CS, Döhner H, Gale RP, et al. HLA-identical sibling allogeneic transplants versus chemotherapy in acute myelogenous leukemia with t(8;21) in first complete remission: collaborative study between the German AML Intergroup and CIBMTR. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 14: 187-96. PMID 18215779 DOI: 10.1016/j.bbmt.2007.10.006 |
0.437 |
|
| 2008 |
Logan BR, Klein JP, Zhang MJ. Comparing treatments in the presence of crossing survival curves: an application to bone marrow transplantation. Biometrics. 64: 733-40. PMID 18190619 DOI: 10.1111/J.1541-0420.2007.00975.X |
0.415 |
|
| 2008 |
Hari P, Majhail NS, Hassebroek A, Zhang M, Siddiqui F, Mehta P. Similar Outcomes among African-Americans (AA) and Whites after Autologous Hematopoietic-Cell Transplantation (Auto HCT) for Multiple Myeloma (MM) Blood. 112: 740-740. DOI: 10.1182/Blood.V112.11.740.740 |
0.466 |
|
| 2008 |
Freytes CO, Carreras J, Zhang M, Laport GG, Besien KV, Lazarus HM, Hari P. Non-Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (NMHCT) for Patients Relapsing after Autologous Stem Cell Transplantation (autoHCT) for B Cell Non-Hodgkin Lymphoma (NHL) Blood. 112: 459-459. DOI: 10.1182/Blood.V112.11.459.459 |
0.514 |
|
| 2008 |
Luger S, Ringden O, Peréz WS, Zhang M, DiPersio JF, Sierra J, Tallman M, Weisdorf DJ, Pulsipher M. Similar Outcomes Using Myeloablative Versus Reduced Intensity and Non-Myeloablative Allogeneic Transplant Preparative Regimens for AML or MDS: From the Center for International Blood and Marrow Transplant Research Blood. 112: 348-348. DOI: 10.1182/Blood.V112.11.348.348 |
0.535 |
|
| 2008 |
Locatelli F, Moreno-Madureira A, Teira P, Eapen M, Zhang M, Davies SM, Picardi A, Woolfrey AE, Chan KW, Socie G, Vora AJ, Bertrand Y, Kurtzberg J, Bonfim C, Gluckman E, et al. Encoraging Results after Alternative Donor Transplantation for Myelodysplastic Syndrome. Blood. 112: 1964-1964. DOI: 10.1182/Blood.V112.11.1964.1964 |
0.547 |
|
| 2008 |
Beksac M, Maiers M, Gragert L, Spellman S, Shrestha S, Zhang M, Dispenzieri A, Reece DE, Vesole DH, Hari P. HLA Specificities and Predisposition to the Development of Multiple Myeloma (MM). Blood. 112: 1688-1688. DOI: 10.1182/Blood.V112.11.1688.1688 |
0.313 |
|
| 2008 |
Zhang X, Loberiza FR, Klein JP, Zhang M. Erratum to “A SAS macro for estimation of direct adjusted survival curves based on a stratified Cox regression model” [Comput. Meth. Prog. Biomed. 88 (2007) 95–101] Computer Methods and Programs in Biomedicine. 89: 313-314. DOI: 10.1016/J.Cmpb.2007.11.003 |
0.304 |
|
| 2007 |
Dong L, Wu T, Zhang MJ, Gao ZY, Lu DP. CD3+ cell dose and disease status are important factors determining clinical outcomes in patients undergoing unmanipulated haploidentical blood and marrow transplantation after conditioning including antithymocyte globulin. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 13: 1515-24. PMID 18022582 DOI: 10.1016/J.Bbmt.2007.09.007 |
0.52 |
|
| 2007 |
Zhang X, Loberiza FR, Klein JP, Zhang MJ. A SAS macro for estimation of direct adjusted survival curves based on a stratified Cox regression model. Computer Methods and Programs in Biomedicine. 88: 95-101. PMID 17850917 DOI: 10.1016/J.Cmpb.2007.07.010 |
0.426 |
|
| 2007 |
Giralt S, Logan B, Rizzo D, Zhang MJ, Ballen K, Emmanouilides C, Nath R, Parker P, Porter D, Sandmaier B, Waller EK, Barker J, Pavletic S, Weisdorf D. Reduced-intensity conditioning for unrelated donor progenitor cell transplantation: long-term follow-up of the first 285 reported to the national marrow donor program. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 13: 844-52. PMID 17580263 DOI: 10.1016/J.Bbmt.2007.03.011 |
0.525 |
|
| 2007 |
Zhang MJ, Chu KD, Cheng XL, Pan XD, Cheng WJ, Yu KY, Tan YH, Liu JZ, Shi YL, Zheng S, Liu QB. [Aike mixture has good anti-inflammatory and analgesic effects on mice]. Zhonghua Nan Ke Xue = National Journal of Andrology. 13: 471-3. PMID 17569268 |
0.333 |
|
| 2007 |
Eapen M, Rubinstein P, Zhang MJ, Stevens C, Kurtzberg J, Scaradavou A, Loberiza FR, Champlin RE, Klein JP, Horowitz MM, Wagner JE. Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study. Lancet. 369: 1947-54. PMID 17560447 DOI: 10.1016/S0140-6736(07)60915-5 |
0.356 |
|
| 2007 |
Wagner JE, Eapen M, MacMillan ML, Harris RE, Pasquini R, Boulad F, Zhang MJ, Auerbach AD. Unrelated donor bone marrow transplantation for the treatment of Fanconi anemia. Blood. 109: 2256-62. PMID 17038525 DOI: 10.1182/blood-2006-07-036657 |
0.4 |
|
| 2007 |
Kumar S, Pérez WS, Zhang M, Bredeson CN, Lacy MQ, Milone G, Reece D, Vesole DH, Hari P. Comparable Outcomes in Secretory (SM) Versus Non-Secretory (NSM) Multiple Myeloma (MM) with Autologous Hematopoietic Stem Cell Transplantation (AuHCT). Blood. 110: 944-944. DOI: 10.1182/Blood.V110.11.944.944 |
0.526 |
|
| 2007 |
Hari P, Pérez W, Zhang M, Bredeson C, Milone G, Reece D, Roy V, Vesole D. Current Staging Systems Are Inadequate Predictors of Treatment Failure after Autologous Hematopoietic Stem Cell Transplants (AuHCT) in Multiple Myeloma (MM). Blood. 110: 938-938. DOI: 10.1182/Blood.V110.11.938.938 |
0.471 |
|
| 2007 |
Collins N, Gee AP, Durrett A, Kan F, Zhang M, Champlin RE, Confer D, Eapen M, Wagner JE, Horowitz MM, Weisdorf DJ. Graft Composition and Outcomes in Unrelated Donor Transplantation. Blood. 110: 3065-3065. DOI: 10.1182/Blood.V110.11.3065.3065 |
0.365 |
|
| 2007 |
Marks DI, Pérez WS, He V, Zhang M, Keating A, Tallman M, Sierra J, Weisdorf D. Unrelated Donor (URD) Hematopoietic Stem Cell Transplantation (HCT) for Adults with Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia (ALL) in First Complete Remission (CR1): A Center for International Blood and Marrow Transplant Research (CIBMTR) Analysis. Blood. 110: 3055-3055. DOI: 10.1182/Blood.V110.11.3055.3055 |
0.521 |
|
| 2007 |
Fenske TS, Hari P, Carreras J, Zhang M, Kamble R, Rizzo JD, Besien Kv, Lazarus HM, Vose JM. Pre-Transplant Rituximab Therapy Is Associated with Improved Progression-Free and Overall Survival in Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation for Diffuse Large B-Cell Lymphoma (DLBCL). Blood. 110: 19-19. DOI: 10.1182/Blood.V110.11.19.19 |
0.49 |
|
| 2007 |
Hahn T, McCarthy PL, Wang D, Zhang M, Aurora M, Pavletic S, Barrett AJ, Ringden O. Risk Factors for Acute Graft-Versus-Host Disease (GvHD) after Related Donor HLA-Matched Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Adult Leukemia: Identification of Modifiable and Non-Modifiable Factors. A CIBMTR Study. Blood. 110: 1069-1069. DOI: 10.1182/Blood.V110.11.1069.1069 |
0.469 |
|
| 2007 |
Klein JP, Zhang MJ. 9 Survival Analysis Handbook of Statistics. 27: 281-320. DOI: 10.1016/S0169-7161(07)27009-9 |
0.321 |
|
| 2006 |
Wang LR, Dong LJ, Zhang MJ, Lu DP. The impact of human herpesvirus 6B reactivation on early complications following allogeneic hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 12: 1031-7. PMID 17067909 DOI: 10.1016/J.Bbmt.2006.06.001 |
0.435 |
|
| 2006 |
Schmitz N, Eapen M, Horowitz MM, Zhang MJ, Klein JP, Rizzo JD, Loberiza FR, Gratwohl A, Champlin RE. Long-term outcome of patients given transplants of mobilized blood or bone marrow: A report from the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation. Blood. 108: 4288-90. PMID 16946302 DOI: 10.1182/Blood-2006-05-024042 |
0.412 |
|
| 2006 |
Eapen M, Raetz E, Zhang MJ, Muehlenbein C, Devidas M, Abshire T, Billett A, Homans A, Camitta B, Carroll WL, Davies SM. Outcomes after HLA-matched sibling transplantation or chemotherapy in children with B-precursor acute lymphoblastic leukemia in a second remission: a collaborative study of the Children's Oncology Group and the Center for International Blood and Marrow Transplant Research. Blood. 107: 4961-7. PMID 16493003 DOI: 10.1182/blood-2005-12-4942 |
0.4 |
|
| 2006 |
Lazarus HM, Pérez WS, Klein JP, Kollman C, Bate-Boyle B, Bredeson CN, Gale RP, Geller RB, Keating A, Litzow MR, Marks DI, Miller CB, Douglas Rizzo J, Spitzer TR, Weisdorf DJ, ... Zhang MJ, et al. Autotransplantation versus HLA-matched unrelated donor transplantation for acute myeloid leukaemia: a retrospective analysis from the Center for International Blood and Marrow Transplant Research. British Journal of Haematology. 132: 755-69. PMID 16487177 DOI: 10.1111/J.1365-2141.2005.05947.X |
0.414 |
|
| 2006 |
Tallman MS, Pérez WS, Lazarus HM, Gale RP, Maziarz RT, Rowe JM, Marks DI, Cahn JY, Bashey A, Bishop MR, Christiansen N, Frankel SR, GarcÃa JJ, Ilhan O, Laughlin MJ, ... ... Zhang MJ, et al. Pretransplantation consolidation chemotherapy decreases leukemia relapse after autologous blood and bone marrow transplants for acute myelogenous leukemia in first remission. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 12: 204-16. PMID 16443518 DOI: 10.1016/j.bbmt.2005.10.013 |
0.342 |
|
| 2006 |
Logan BR, Zhang MJ, Klein JP. Regression models for hazard rates versus cumulative incidence probabilities in hematopoietic cell transplantation data. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 12: 107-12. PMID 16399594 DOI: 10.1016/J.Bbmt.2005.09.005 |
0.415 |
|
| 2006 |
Eapen M, Rubinstein P, Zhang MJ, Camitta BM, Stevens C, Cairo MS, Davies SM, Doyle JJ, Kurtzberg J, Pulsipher MA, Ortega JJ, Scaradavou A, Horowitz MM, Wagner JE. Comparable long-term survival after unrelated and HLA-matched sibling donor hematopoietic stem cell transplantations for acute leukemia in children younger than 18 months. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 24: 145-51. PMID 16382124 DOI: 10.1200/JCO.2005.02.4612 |
0.355 |
|
| 2006 |
Lu DP, Dong L, Wu T, Huang XJ, Zhang MJ, Han W, Chen H, Liu DH, Gao ZY, Chen YH, Xu LP, Zhang YC, Ren HY, Li D, Liu KY. Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation. Blood. 107: 3065-73. PMID 16380454 DOI: 10.1182/Blood-2005-05-2146 |
0.526 |
|
| 2006 |
Bashey A, Perez WS, Zhang M, Vesole DH, Reece DE, Goldschmidt H, Hari P. Outcomes Following Syngeneic Hematopoietic Stem Cell Transplantation for Multiple Myeloma: A Matched Comparison to Autologous Transplantation. Blood. 108: 50-50. DOI: 10.1182/Blood.V108.11.50.50 |
0.529 |
|
| 2006 |
Eapen M, Zhang M, Raetz E, Devidas M, Carroll WL, Ritchey AK, Barredo JC, Godder K, Grupp SA, Lewis VA, Davies S, Camitta B. Outcomes after HLA-Matched Sibling Transplants or Chemotherapy in Children with Acute Lymphoblastic Leukemia in a Second Remission after an Isolated Central Nervous System Relapse. Blood. 108: 49-49. DOI: 10.1182/Blood.V108.11.49.49 |
0.532 |
|
| 2006 |
Eapen M, Rubinstein P, Zhang M, Stevens C, Kurtzberg J, Scaradavou A, Horowitz MM, Wagner JE. Unrelated Donor Hematopoietic Stem Cell Transplantation (HSCT) in Children with Acute Leukemia: Risks and Benefits of Umbilical Cord Blood (CB) Versus HLA A, B, C, DRB1 Allele-Matched Bone Marrow (BM). Blood. 108: 434-434. DOI: 10.1182/Blood.V108.11.434.434 |
0.445 |
|
| 2006 |
Hayes-Lattin B, Carreras J, Zhang M, Besien Kv, Vose JM, Lazarus HM, Rizzo JD, Hari P. Superior Survival after Autologous vs. Allogeneic Hematopoietic Stem Cell Transplantation (HCT) for Diffuse Large B-Cell Lymphoma (DLBCL) Not Explained by Differences in Chemosensitivity. Blood. 108: 3021-3021. DOI: 10.1182/Blood.V108.11.3021.3021 |
0.491 |
|
| 2005 |
Logan BR, Wang H, Zhang MJ. Pairwise multiple comparison adjustment in survival analysis. Statistics in Medicine. 24: 2509-23. PMID 15977296 DOI: 10.1002/Sim.2125 |
0.41 |
|
| 2005 |
Loberiza FR, Zhang MJ, Lee SJ, Klein JP, LeMaistre CF, Serna DS, Eapen M, Bredeson CN, Horowitz MM, Rizzo JD. Association of transplant center and physician factors on mortality after hematopoietic stem cell transplantation in the United States. Blood. 105: 2979-87. PMID 15598815 DOI: 10.1182/Blood-2004-10-3863 |
0.471 |
|
| 2005 |
Oh H, Loberiza FR, Zhang MJ, Ringdén O, Akiyama H, Asai T, Miyawaki S, Okamoto S, Horowitz MM, Antin JH, Bashey A, Bird JM, Carabasi MH, Fay JW, Gale RP, et al. Comparison of graft-versus-host-disease and survival after HLA-identical sibling bone marrow transplantation in ethnic populations. Blood. 105: 1408-16. PMID 15486071 DOI: 10.1182/blood-2004-06-2385 |
0.379 |
|
| 2005 |
Ballen K, Sobocinski KA, Zhang M, Arora M, Horowitz MM, Giralt S. Outcome of Bone Marrow Transplantation for Myelofibrosis. Blood. 106: 170-170. DOI: 10.1182/Blood.V106.11.170.170 |
0.475 |
|
| 2005 |
Pasquini MC, Perez W, Zhang M, Schlenk RF, Ganser A. Comparison of HLA-Identical Sibling Hematopoietic Stem Cell Transplant (HCT) Versus Chemotherapy as Postremission Therapy in t(8;21) Acute Myeloid Leukemia (AML). Blood. 106: 1138-1138. DOI: 10.1182/Blood.V106.11.1138.1138 |
0.505 |
|
| 2004 |
Godder K, Eapen M, Laver JH, Zhang MJ, Camitta BM, Wayne AS, Gale RP, Doyle JJ, Yu LC, Chen AR, Garvin JH, Sandler ES, Yeager AM, Edwards JR, Horowitz MM. Autologous hematopoietic stem-cell transplantation for children with acute myeloid leukemia in first or second complete remission: a prognostic factor analysis. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 3798-804. PMID 15365077 DOI: 10.1200/JCO.2004.12.142 |
0.315 |
|
| 2004 |
Freytes CO, Loberiza FR, Rizzo JD, Bashey A, Bredeson CN, Cairo MS, Gale RP, Horowitz MM, Klumpp TR, Martino R, McCarthy PL, Molina A, Pavlovsky S, Pecora AL, Serna DS, ... ... Zhang MJ, et al. Myeloablative allogeneic hematopoietic stem cell transplantation in patients who experience relapse after autologous stem cell transplantation for lymphoma: a report of the International Bone Marrow Transplant Registry. Blood. 104: 3797-803. PMID 15280203 DOI: 10.1182/blood-2004-01-0231 |
0.422 |
|
| 2004 |
Loberiza FR, Zhang M, Rizzo JD, Lee SJ, Klein JP, Logan BR, Eapen M, Serna DS, Lemaistre CF, Horowitz MM. Patient and transplant center factors associated with 100D mortality after receiving allogeneic hematopoietic stem cell transplantation (HSCT) Journal of Clinical Oncology. 22: 6026-6026. DOI: 10.1200/Jco.2004.22.90140.6026 |
0.435 |
|
| 2003 |
Serna DS, Lee SJ, Zhang MJ, Baker kS, Eapen M, Horowitz MM, Klein JP, Rizzo JD, Loberiza FR. Trends in survival rates after allogeneic hematopoietic stem-cell transplantation for acute and chronic leukemia by ethnicity in the United States and Canada. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 21: 3754-60. PMID 14551294 DOI: 10.1200/Jco.2003.03.133 |
0.467 |
|
| 2003 |
Levine JE, Harris RE, Loberiza FR, Armitage JO, Vose JM, Van Besien K, Lazarus HM, Horowitz MM, Bashey A, Bolwell BJ, Burns LJ, Cairo MS, Champlin RE, Freytes CO, Gibson J, ... ... Zhang MJ, et al. A comparison of allogeneic and autologous bone marrow transplantation for lymphoblastic lymphoma. Blood. 101: 2476-82. PMID 12456505 DOI: 10.1182/blood-2002-05-1483 |
0.434 |
|
| 2002 |
Zhang M. Cox proportional hazards regression models for survival data in cancer research. Cancer Treatment and Research. 113: 59-70. PMID 12613350 DOI: 10.1007/978-1-4757-3571-0_4 |
0.367 |
|
| 2001 |
Keever-Taylor CA, Bredeson C, Loberiza FR, Casper JT, Lawton C, Rizzo D, Burns WH, Margolis DA, Vesole DH, Horowitz M, Zhang M, Juckett M, Drobyski WR. Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion. Biology of Blood and Marrow Transplantation. 7: 620-630. PMID 11760150 DOI: 10.1053/Bbmt.2001.V7.Pm11760150 |
0.475 |
|
| 2001 |
Miller CB, Rowlings PA, Zhang MJ, Jones RJ, Piantadosi S, Keating A, Armitage JO, Calderwood S, Harris RE, Klein JP, Lazarus HM, Linker CA, Sobocinski KA, Weisdorf D, Horowitz MM. The effect of graft purging with 4-hydroperoxycyclophosphamide in autologous bone marrow transplantation for acute myelogenous leukemia. Experimental Hematology. 29: 1336-46. PMID 11698130 DOI: 10.1016/S0301-472X(01)00732-9 |
0.436 |
|
| 2001 |
Zhang MJ, Klein JP. Confidence bands for the difference of two survival curves under proportional hazards model. Lifetime Data Analysis. 7: 243-54. PMID 11677829 DOI: 10.1023/A:1011636407958 |
0.393 |
|
| 2000 |
Tallman MS, Rowlings PA, Milone G, Zhang M, Perez WS, Weisdorf D, Keating A, Gale RP, Geller RB, Laughlin MJ, Lazarus HM, Luger SM, McCarthy PL, Rowe JM, Saez RA, et al. Effect of postremission chemotherapy before human leukocyte antigen–identical sibling transplantation for acute myelogenous leukemia in first complete remission Blood. 96: 1254-1258. DOI: 10.1182/Blood.V96.4.1254 |
0.517 |
|
| 2000 |
Barrett AJ, Ringdén O, Zhang M, Bashey A, Cahn J, Cairo MS, Gale RP, Gratwohl A, Locatelli F, Martino R, Schultz KR, Tiberghien P. Effect of nucleated marrow cell dose on relapse and survival in identical twin bone marrow transplants for leukemia. Blood. 95: 3323-3327. DOI: 10.1182/Blood.V95.11.3323.011K30_3323_3327 |
0.483 |
|
| 1999 |
Andersen PK, Horowitz MM, Klein JP, Socie G, Stone JV, Zhang MJ. Modelling covariate adjusted mortality relative to a standard population. Statistics in Medicine. 18: 1529-40. PMID 10398290 DOI: 10.1002/(Sici)1097-0258(19990630)18:12<1529::Aid-Sim137>3.0.Co;2-J |
0.434 |
|
| 1999 |
Andersen PK, Klein JP, Zhang MJ. Testing for centre effects in multi-centre survival studies: a Monte Carlo comparison of fixed and random effects tests. Statistics in Medicine. 18: 1489-500. PMID 10398287 DOI: 10.1002/(Sici)1097-0258(19990630)18:12<1489::Aid-Sim140>3.0.Co;2-# |
0.313 |
|
| 1999 |
Horowitz MM, Przepiorka D, Bartels P, Buell DN, Zhang M, Fitzsimmons WE, Erdman J, Huang C, Hodosh E, Maher R, Wingard JR. Tacrolimus vs. cyclosporine immunosuppression: results in advanced-stage disease compared with historical controls treated exclusively with cyclosporine. Biology of Blood and Marrow Transplantation. 5: 180-186. PMID 10392964 DOI: 10.1053/Bbmt.1999.V5.Pm10392964 |
0.475 |
|
| 1999 |
Klein JP, Zhang M. Determining when the survival rates of two treatments are the same based on a censored data regression model Journal of Statistical Planning and Inference. 78: 243-254. DOI: 10.1016/S0378-3758(98)00217-1 |
0.402 |
|
| 1997 |
Jagannath S, Vesole DH, Zhang M, Desikan KR, Copeland N, Jagannath M, Bracy D, Jones R, Crowley J, Tricot G, Barlogie B. Feasibility and cost-effectiveness of outpatient autotransplants in multiple myeloma. Bone Marrow Transplantation. 20: 445-50. PMID 9313876 DOI: 10.1038/Sj.Bmt.1700900 |
0.474 |
|
| Show low-probability matches. |